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Cardiovascular disease (CVD) is the leading global cause of mortality and the 
underlying atherosclerotic disease process which precedes overt CVD 
originates in youth. Consumption of sugar-sweetened beverages (SSB) are 
associated with CVD risk factors in youth and SSB intake is a key contributor to 
added dietary sugar intake in teenagers in the United Kingdom. Endothelial 
dysfunction is a prerequisite for atherosclerosis and previous research 
demonstrates that SSB consumption acutely impairs endothelial function. 
However, these studies have predominantly focused on adult populations, or 
have used a glucose bolus which is not representative of the sugar found in 
commercially available SSBs. The purpose of this thesis was to investigate the 
influence of different dietary sugars found in SSBs on macrovascular and 
microvascular outcomes and then observe whether the sugar type influences 
the cardiometabolic responses to a subsequent test meal challenge. This thesis 
also determined the reliability of measures for the assessment of macrovascular 
(flow-mediated dilation; FMD) and microvascular (laser Doppler flowmetry) 
function. Chapter 4: Assessed the within-day and between day reliability of the 
simultaneous assessment of macrovascular and microvascular function. The 
within-day and between-day typical error expressed as a coefficient of variation 
were as follows: FMD, 7.2% and 8.0%; peak reactive hyperaemia (PRH), 24.5% 
and 26.1%. These results determined that the reliability of outcomes in this 
study were consistent with existing paediatric data. Chapter 5: There was a 
large (ηp2=0.27) but not significant (P=0.06) interaction effect for FMD.  There 
was a non-significant difference between the sucrose and control trials for FMD 
at 1 hour post drink consumption (P=0.06) and 3 hours post test meal 
consumption (P=0.09) but there was a medium effect at both times with effect 
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sizes of 0.77 and 0.65, respectively, where FMD increased following sucrose 
consumption. PRH increased 1 hour post drink consumption in the fructose 
(P=0.01), glucose (P=0.04) and sucrose trials (P=0.04) when compared to 
control. PRH was greater in the fructose trial when compared to the control 
(P=0.03), glucose (P=0.01) and sucrose (P=0.02) trials. These findings suggest 
that SSB intake acutely improves macro- and micro- vascular function in 
adolescents. Overall, these findings provide important information in regards to 
























Chapter 1: Introduction 
1.1 Cardiovascular Disease  
In 2012, out of the 56 million deaths which occurred globally, 38 million of these 
were due to noncommunicable diseases (cardiovascular disease [CVD], cancer, 
respiratory diseases and diabetes) (WHO, 2014). Cardiovascular diseases were 
responsible for 46% (17.5 million) of these deaths making them the leading 
cause of mortality globally (WHO, 2016a). Eighty percent of CVD deaths are 
caused by stroke or heart attack and a third of these deaths are in people under 
the age of 70 years (WHO, 2016a). Furthermore, CVD accounted for 125,000 of 
the 491,000 deaths which occurred in the UK in 2016 (British Heart Foundation, 
2018a). More specifically, CVDs were responsible for 25% of deaths in men and 
17% of deaths in women under the age of 75 years (British Heart Foundation, 
2018a). As the average life expectancy in the UK is 79.2 years for males and 
82.9 years for females (Office for National Statistics, 2018) these statistics 
highlight the significant role CVD plays in early mortality in the UK.  
Over the past 20 years significant reductions in CVD mortality have been 
observed in high-income countries as a result of government policies which 
facilitate adoptions of healthier lifestyles and improvements in available 
healthcare (WHO, 2014). However, data from the British Heart Foundation 
(2018b) found that people in the UK living with CVD had increased from 7.3% in 
1988 to 11.1% in 2011 in men and from 7.7% to 9.1% in women, respectively. 
This could be explained by advances in CVD healthcare which has resulted in 
people living with CVD for longer. However, this in turn causes an increase in 
healthcare costs and a recent European report estimated the total annual 
healthcare cost of CVD in the UK was £24 billion in 2015 (European Heart 
Network, 2017) and with the associated decline in CVD mortality and increase 
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in CVD morbidity the impact of CVD on the economy will continue to rise (Public 
Health England, 2018). The increase of CVD morbidity in the UK makes tackling 
CVD a primary issue and further work needs to be done to reduce healthcare 
costs and to improve standard of life.  
The underlying disease process which causes CVD is atherosclerosis, an 
inflammatory disease which progresses throughout life (Ross, 1999; McGill & 
McMahan, 2003). The primary stage of atherosclerosis is endothelial 
dysfunction, an impairment in functioning of the endothelium, which occurs prior 
to structural changes to the artery (Tounian et al., 2001; Meyer et al., 2006). 
This is followed by the deposition of cholesterol and its entry into the 
subendothelial space to form fatty streaks (McGill & McMahan, 1998). This 
process has been determined to originate during childhood (McGill et al., 
2000a). The probability of an individual developing CVD can be predicted by 
individual characteristics known as a risk factors which include age, male 
gender, family history of precocious heart disease, high total serum cholesterol 
concentration, high low-density lipoprotein (LDL) cholesterol, low high-density 
lipoprotein cholesterol level, smoking hypertension, obesity and diabetes 
(McGill & McMahan 1998). Over many years, in the presence of continued CVD 
risk factor exposure, the proliferation of smooth muscle and connective tissue 
causes foam cell formation alongside the sequestering of lipid rich 
macrophages into the vessel wall which results in the development of a 
fibromuscular cap (McGill & McMahan, 1998). Progression in size continues 
until the lesion has imposed itself on the lumen of the artery which causes it to 
become vulnerable to rupture causing the release of lipid-rich substances into 
the bloodstream (McGill & McMahan, 1998). This leads to the development of a 
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thrombus, promoting occlusion and subsequently leading to a cardiovascular 
event such as myocardial infarction or stroke.  
1.2 Sugar-Sweetened Beverages 
SSBs are made up of equal parts of the sugars fructose and glucose (which 
form the sugar sucrose) and the consumption of fructose has been positively 
associated with CVD risk factors such as obesity, elevated lipid production in 
the liver and high blood pressure independent of glucose (Johnson et al., 2009; 
Bray, 2012; Vartanian et al., 2007; Bray, 2010). Fructose consumption has also 
been associated with an increase in the fractional rate of de novo lipogenesis 
which is implicated in the progression of atherosclerosis (Stanhope et al., 2009; 
Faeh et al., 2005). Adolescents in the UK aged 11 to 18 years consume 191 g 
of SSBs per day which is equal to 22-28 g of sugar (Public Health England, 
2018; Malik et al., 2006). The Scientific Advisory Committee on Nutrition 
recommend that no more than 5% of daily energy intake comes from added 
sugar and current average intake for adolescents is three times this value 
(Scientific Advisory Committee, 2015; Public Health England, 2015). Current 
guidelines recommend a limit of <25 g per day of added sugar for young people 
meaning adolescents in the UK are consuming the recommended maximum 
amount of sugar from SSBs alone (Vos et al., 2017). SSB consumption has 
been linked to increased risk of CVD, coronary heart disease, diabetes and 
CVD risk factors including increased systolic blood pressure, plasma 
[triglyceride] ([TAG]) and adiposity in children and adolescents (Vos et al., 2017; 
Huang et al., 2014; Basu et al., 2013; Chan et al., 2014). With the early 
subclinical manifestations of atherosclerosis and subsequent CVD originating in 
the earlier years it is important to determine whether SSB consumption 
contributes to this process in order to determine CVD risk in this population. 
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This thesis aims to identify the effects of fructose, glucose and sucrose on 
vascular and metabolic function in adolescents to determine whether there is a 


















Chapter 2: Literature Review 
2.1 Paediatric Origins of Atherosclerosis and CVD 
The atherosclerotic disease process originates in childhood and in the 
continued presence of CVD risk factors, can precede overt CVD (Bridger, 
2009). Importantly, it is understood that the atherosclerotic process can be 
expedited by exposure to known CVD risk factors in childhood (Berenson et al., 
1998). We know that the severity of atherosclerotic lesions in the aorta and 
coronary arteries of young people (2 to 39 years) is proportional to known CVD 
risk factors including body mass, elevated blood pressure, serum cholesterol, 
triglycerides, LDL and high-density lipoprotein cholesterol collectively (Berenson 
et al., 1998).  
Holman et al. (1958) initially determined that in the first two decades of life there 
was already a prevalence of fatty streaks in the coronary arteries of New 
Orleans residents. Subsequent research in ~3,000 autopsied young persons 
aged 15 to 34 years who died from noncommunicable deaths (not due to 
communicable or chronic disease), found that very-low density lipoproteins 
(VLDL), LDL, smoking, hypertension, body mass index (BMI) and 
hyperglycaemia were associated with atherosclerotic lesions (McGill et al., 
2000b; McGill et al., 1995; McGill et al., 1997; McGill et al., 1998; McGill et al., 
2002). The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) 
Study developed risk scores to predict the prevalence of advanced lesions in 
adolescents and young adults (McMahan et al., 2005). By using these risk 
scores it was determined that subclinical lesions seen in the early years are 
associated with advanced clinical lesions in later life (McMahan et al., 2006). 
Based on these findings it is suggested that the prevention of CVD needs to 
begin in the early years (McMahan et al., 2005).  
15 
 
Newer noninvasive ultrasound techniques have made it possible to observe 
vascular alterations associated with CVD in living populations (Groner et al., 
2006). Thickening of the intima and media in the carotid artery (carotid intima-
media thickening; cIMT) is associated with known CVD risk factors and 
coronary artery disease (Heiss et al. 1991; Chambless et al., 1997) and is used 
as a marker for atherosclerotic progression in adults and as a predictor of 
cardiovascular events (Bridger, 2009). A recent meta-analysis conducted by the 
International Childhood Cardiovascular Cohort (i3C) Consortium used data from 
the Cardiovascular Risk in Young Finns (Finland), the Childhood Determinants 
of Adults Health (Australia), the Bogalusa Heart (US) and the Muscatine (US) 
studies (Juonala et al., 2010). These studies all measured childhood risk factor 
exposure and followed participants into adulthood and have evidenced that 
atherosclerotic lesions and cIMT at death were associated with CVD risk factor 
exposure during childhood (Juonala et al., 2010). Research has shown that LDL 
level and BMI in childhood were independent predictors of elevated cIMT in 
adulthood (Shengxu et al., 2003). This was supported by further research which 
evidenced that, as well as LDL level and BMI, systolic blood pressure and 
smoking measured during the ages of 12-18 years were independently 
associated with cIMT in adulthood (Raitakari et al., 2003) determining that risk 
factor status in the adolescent years is a strong predictor of cIMT in adulthood. 
Thus, limiting exposure to CVD risk factors in youth is an important 
consideration in the battle against CVD. 
Research regarding the reversibility of cIMT in children and adults is conflicting. 
Studies using exercise interventions have demonstrated that exercise alone 
does not reduce cIMT in patients with diabetes or in obese or overweight 
children and adolescents (Byrkjeland et al., 2016; Ngai & Cheung, 2015). 
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However, cIMT has been shown to reduce following routine care or a controlled 
diet plan (Ngai & Cheung, 2015) and carotid vessel wall volume was also 
attenuated following a 2 year diet intervention (Shai et al., 2010). Further 
research has found that cIMT can be reduced with insulin and oral 
hypoglycemic treatments (Tenjin et al., 2016) and by bariatric surgery in obese 
participants (Garcia et al., 2013). The evidence indicates that non-
pharmacological interventions to reverse cIMT have limited success. Thus, the 
focus of interventions should be on prevention of structural changes through 
either improvement or preservation of vascular function rather than treatment. 
The research discussed provides evidence for the early beginnings of the 
atherosclerotic process and how there is a potential association with 
cardiovascular risk factors. It has been consistently observed that when these 
risk factors are measured during the younger years they predict the extent of 
the atherosclerosis in later life. The evidence provided shows that early risk 
factor exposure can result in clinically significant atherosclerosis in later life. 
Interventions need to occur in youth and should focus on preservation or 
improvement of vascular function. 
2.2 Endothelial Dysfunction 
The endothelium plays a key role in the atherosclerotic process and is 
implicated from the beginning to the clinically advanced stages (Thijssen et al., 
2019). It regulates the tone, growth, adhesion and coagulation of the 
vasculature (Vanhoutte et al., 2009) and is also sensitive to haemodynamic 
stimuli including shear stress and circumferential wall strain (Green et al., 2017; 
Thijssen et al., 2019). Endothelial dysfunction is defined as an impairment in the 
endothelium’s ability to respond to haemodynamic stimuli and is the earliest 
detectable change of the atherosclerotic process preceding any structural 
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change to the vasculature (Ross, 1999). Therefore, function of the endothelium 
is an important outcome to focus on in regards to CVD prevention. 
(Dys)function of the endothelium can be non-invasively assessed using the 
ultrasound based technique of flow-mediated dilation (FMD) of the brachial 
artery (for details please see section 3.5.2) (Celermajer et al., 1992; Corretti et 
al., 2002).  
In studies where FMD was measured on peripheral arterial disease patients, 
those which later suffered a cardiovascular event had a significantly lower FMD 
than those that did not (Brevetti et al., 2003; Gokce et al., 2003). Additionally, 
there was nearly a 5-fold increase in cardiovascular event risk in those with an 
FMD below the median (6.7%) than in those with an FMD above the median 
(Brevetti et al., 2003). Research has also shown that participants with an FMD 
below the median (4.7%) suffered from cardiovascular events more than those 
with an FMD above the median (Muiesan et al., 2008). A meta-analysis of 14 
studies determined that for every 1% increase in FMD the likelihood of a 
cardiovascular event occurring reduced by 13% (Inaba et al., 2010). Another 
meta-analysis of 23 studies found that the pooled overall CVD risk was 0.92 for 
every 1% increase in FMD (Ras et al., 2013). More recently, Matsuzawa et al. 
(2015) systematically reviewed 35 FMD studies and evidenced a relative risk for 
CVD of 0.88 for every 1% increase in FMD. 
In the first study to use FMD, it was found that endothelial dysfunction occurs in 
children present with CVD risk factors (Celermajer et al., 1992). Use of the FMD 
technique has also demonstrated that endothelial dysfunction is present in 
children who are overweight (Woo et al., 2004), obese (Aggoun et al., 2008; 
Tounian et al., 2001), have type 1 diabetes (Jarvisalo et al., 2004) and present 
with hypercholesterolemia (Sorensen et al., 1994). The Cardiovascular Risk in 
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Young Finns cohort demonstrated that in young adults the number of CVD risk 
factors were only predictive of an elevated cIMT in those with an FMD in the 
tenth percentile (FMD of 1.1+1.4%) (Juonala et al., 2004). This association was 
no longer present in participants when endothelial function was not impaired 
proposing that even in the presence of risk factors, if endothelial function is 
maintained then the likelihood of developing atherosclerosis is reduced 
(Juonala et al., 2004). This suggests that by preventing endothelial dysfunction 
this can protect against atherosclerotic related change even when exposed to 
risk factors. These findings have been supported by Hopkins et al. (2013) where 
it was determined in children aged 10 years that there was no association 
between changes in FMD occurring over a 30 month period and cIMT 
measured at 30 months. This suggests that endothelial dysfunction needs to 
occur over a longer period of time before any atherosclerotic changes take 
place. Preventing an impairment in endothelial function even in early life is 
therefore important (Hopkins et al., 2013).  
It has been shown that impaired macrovascular endothelial function occurs prior 
to any atherosclerotic change in children, adolescents and adults. It is also 
known that that microvascular function can be impaired in the presence of CVD 
risk factors. Evidence has shown an inverse association between microvascular 
function and CVD risk factors in 11 to 14 year old children (Khan et al., 2003). 
Further research has demonstrated that microvascular function is impaired in 
the presence elevated blood pressure and insulin resistance in adults 
(Wascher, 1997; Serne et al., 1999). More recently, a study of 1500 vascular 
disease free men found that microvascular function and cIMT predicted later 
cardiovascular events (Anderson et al., 2011). Interestingly, in the same study 
FMD was not associated with subsequent cardiovascular events which 
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suggests that microvascular function provides important prognostic information 
which cannot be captured using FMD.  
The literature behind the mechanisms of microvascular function are currently 
limited however, it has been proposed that there are four major factors which 
are involved in the hyperaemic response (Cracowski et al., 2006). These four 
factors include metabolic vasodilators, endothelial vasodilators, the myogenic 
response and sensory nerves (Cracowski et al., 2006). Nitric oxide (NO), an 
endothelial vasodilator, has been reported not to be crucial in the response. 
Wong et al. (2003) demonstrated that NO synthase inhibition by infusion of NG-
nitro-l-arginine methyl ester into the forearm did not influence the hyperaemic 
response. Another study, which assessed [NO] by using a NO selective 
amperometric electrode inserted into the skin of the forearm, found that [NO] did 
not increase during reactive hyperaemia in the skin of the forearm (Zhao et al., 
2004). Engelke et al. (1996) also demonstrated that total hyperaemic response 
remained unchanged before and after administration of the NO synthase 
inhibitor NG-monomethyl-L-arginine. However, this study also demonstrated a 
33% reduction in the total hyperaemic response when ibuprofen (which inhibits 
prostaglandins) was administered before the NO synthase inhibitor. This 
suggests that prostaglandin inhibition might determine a role for NO in the 
reactive hyperaemic response. It has also been demonstrated that combined 
sensory nerve and prostaglandin inhibition caused a 72% reduction in the post-
occlusive response (Larkin & Williams, 1993). Thus, the mechanisms behind 
the microvasculature are most likely attributed to a series of interactions of 
endothelium dependent and independent mechanisms.  
FMD assesses the function of the brachial artery which is a NO dependent 
process when the pneumatic cuff is placed distal to the ultrasound probe and 
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inflated for a period of 5 min at a pressure of 220mmHg (Thijssen et al., 2019). 
Post-occlusive reactive hyperaemia of the cutaneous circulation assesses the 
function of the small capillaries located in the forearm and is not dependent on 
NO (Wong et al., 2003). We also know that FMD and post-occlusive reactive 
hyperaemia do not significantly correlate (Dhindsa et al., 2008). Therefore, 
microvascular function cannot be inferred by FMD and must also be measured. 
Additionally, the earliest detectable manifestations of the metabolic syndrome 
occur at the microvascular level (Pinkney et al., 1997).  
It was shown that little association existed between macro- and micro- vascular 
function in a study which assessed FMD, reactive hyperaemic flow, hyperaemic 
shear stress and reactive hyperaemia index in 40 healthy normotensive adults 
(Dhindsa et al., 2008). Although FMD was positively associated with reactive 
hyperaemic index, it was not associated with hyperaemic flow or hyperaemic 
shear stress. However, this study assessed microvascular function using finger 
plethysmography. A study which assessed macro- and micro- vascular function 
showed there was no association between FMD and laser Doppler imaging in 
coronary artery disease patients (Shamim-Uzzaman et al., 2002). This study 
also suggested that microvascular function was a greater predictor of coronary 
artery disease than macrovascular function. More recent research has 
supported the notion that macro- and micro- vascular function are unrelated 
where it was shown that FMD had no association with microvascular cutaneous 
reactive hyperaemia and acetylcholine-induced microvascular vasodilation (Gori 
et al., 2006). Given the contrasting views in the literature it would be prudent for 
research to measure both macro- and micro- vascular function, as both are 
important and one cannot be inferred from the other. Prior research has used 
laser Doppler imaging to assess microvascular function by post-occlusive 
21 
 
reactive hyperaemia (Schlager et al., 2011). Furthermore, Bond et al. (2016) 
has demonstrated that microvascular function can be assessed simultaneously 
and noninvasively alongside the FMD protocol to reliably determine vascular 
function in adolescents.  
Research which has assessed the predictability of microvascular function for 
cardiovascular events in ~300 cardiac patients found that in patients in the 
lower 2 tertiles (tertiles were divided according to the ΔCVR [coronary vascular 
resistance] with intracoronary acetylcholine) events occurred in 14.1% of 
patients and in the highest tertile this percentage was 5.8% (Halcox et al., 
2002). Another study prospectively assessed FMD of the brachial artery in ~430 
asymptomatic adults with an average age of 54 years (Shechter et al., 2009). 
Here they divided subjects into two groups, those with an FMD either above or 
below the median of 10.7%. These groups also factored in how comparable 
subjects were for coronary artery disease risk factors including age, sex, 
smoking, diabetes, hypercholesterolemia, hypertension and BMI as well as 
lipoproteins, fasting glucose, C-reactive protein and concomitant medications. 
After a 32 month follow up it was determined that cardiovascular events were 
significantly more common in subjects with an FMD below the median. 
Additionally, it was found that median FMD significantly predicted 
cardiovascular events with an odds ratio of 2.78 (95% CI=1.35 to 5.71). A 
multivariate analysis which included conventional risk factors for coronary artery 
disease also found that median FMD was the best significant independent 
predictor of long term cardiovascular adverse events with an odds ratio of 2.70 
(95% CI=1.16 to 6.32).These findings indicate that the functioning of the 




2.3 Sugar and cardiovascular risk 
Adolescents in the UK aged 11 to 18 years consume 191 g of SSBs per day 
which is equal to 22-28 g of sugar (Public Health England, 2018; Malik et al., 
2006). Current guidelines recommend a limit of <25 g per day of added sugar 
for young people meaning adolescents in the UK are consuming the 
recommended maximum amount of sugar from SSBs alone (Vos et al., 2017). 
Additionally, the Scientific Advisory Committee on Nutrition recommend that 
added sugars should represent no more than 5% of daily energy intake 
however current average intake for adolescents is three times this value 
(Scientific Advisory Committee, 2015; Public Health England, 2015).  
The health concerns associated with SSB consumption in the UK has been 
highlighted by a recent sugar tax on SSBs. This tax was introduced to tackle 
childhood obesity, type 2 diabetes and other health issues caused from sugar 
consumption. As a result, over 50% of SSB manufacturers have reduced the 
sugar content of their drinks equivalent to 45 million kg of sugar ever year 
(GOV.UK, 2018). This evidences the relevance of the current project and the 
importance of understanding the effects overconsumption of sugar has on 
youth. 
A recent meta-analysis of four studies which used participants aged 9 to 28 
years determined risk of coronary heart disease is increased by 16% by a one-
serving per day increase in SSBs (Huang et al., 2014). The American Heart 
Association provided a scientific statement that determined that added sugars in 
the diet increase CVD risk in children due to increased adiposity and 
dyslipidemia (Vos et al., 2017). Importantly, these outcomes were present at 
levels far below current levels of consumption (Vos et al. 2017). A study which 
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used econometric models of repeated cross-sectional data on diabetes and 
nutritional components of food from 175 countries it was found that ~1 can of 
SSB per day increased diabetes prevalence by 1.1% (Basu et al., 2013). A 
cross-sectional study by Chan et al. (2014) assessed the effects of dietary SSB 
intake in ~2700 Vietnamese 12 to 16 year olds. It was found that increased 
consumption of SSB per week was associated with greater waist circumference 
in both sexes and systolic blood pressure in boys. High and moderate SSB 
consumption was also associated with a significantly higher level of plasma 
[TAG] in boys (8.0 and 8.2 mg/dL) than non-SSB consumers. Furthermore, 
consumption of >500 mL/day of SSB was associated with a 10-fold increase in 
metabolic syndrome risk in boys. A prospective study assessed SSB intake and 
CVD risk factors in adolescent girls from the ages of 14 to 17 years and found 
that those in the top tertile of SSB consumption (>1.3 servings per day) 
demonstrated an increase in BMI, body weight and obesity risk and a greater 
overall cardiometabolic risk (Ambrosini et al., 2013). Another prospective study 
assessed added sugars and CVD risk factors in children aged 8 to 10 years and 
followed them up 2 years later and determined that a higher consumption of 
added sugar from liquid sources (10 grams per day) was associated with higher 
plasma [glucose] and [insulin] and an increase in insulin resistance and these 
were elevated in overweight or obese children (Wang et al., 2014). 
A recent meta-analysis of 39 studies which assessed the influence of acute 
hyperglycaemia from SSB consumption on macro- and micro- vascular function 
concluded that SSB consumption negatively influences vascular function in 
healthy and diseased adults (Loader et al., 2015).  However, this conclusion is 
not consistent with the limited paediatric data available. Dengel et al. (2007) 
assessed the effects of an oral glucose tolerance test (OGTT) (1.75 g of 
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glucose per kg in body weight) on FMD before and 30, 60 and 120 minutes after 
ingestion in healthy and obese adolescents. Here it was found that the OGTT 
increased FMD by ~2% in the healthy group but there was no change in FMD in 
the obese group. Another paediatric study assessed the effects of acute 
hyperglycaemia compared to euglycaemia on forearm vascular resistance in 
adolescents with type 1 diabetes (Dye et al., 2012). In this study glucose and 
dextrose was infused into an antecubital vein to raise plasma [glucose] to 200 
mg/dL for 60 minutes for the hyperglycaemic state. It was determined that acute 
hyperglycaemia caused a significant decrease in preocclusion forearm vascular 
resistance and the postocclusion fall in forearm vascular resistance was 
reduced when compared to euglycaemia. This resulted in an increase in 
vascular function as opposed to the adult data reported in Loader et al., (2015) 
which reported attenuations in FMD following SSB ingestion.  
The literature currently states that SSB consumption does not lower vascular 
function in youth. However, these studies have predominantly focused on 
findings from adult populations. Only 2 of the articles cited in the meta-analysis 
by Loader et al. (2015) were conducted on youth meaning the conclusions 
drawn are unrepresentative of the paediatric population. Furthermore, these 
studies have concentrated on OGTT which are not representative of 
commercially available SSBs. 27 of the 39 articles cited by Loader et al. (2015) 
used glucose as the sugar when assessing the effects on vascular function and 
only 2 reported using the sugar known as sucrose. However, the main sugars in 
commercially available SSBs are sucrose or high-fructose corn syrup. Sucrose 
is a disaccharide equally composed of the monosaccharides glucose and 
fructose and high-fructose corn syrup is predominantly made up of the 
monosaccharide fructose. These sugars are metabolised differently and the 
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effects these have on the vasculature and CVD risk may differ (Lustig, 2012). It 
is understood that the ratio of fructose to glucose in popular SSBs is 50:50 
(sucrose) but Walker et al. (2014) have reported this to be 60:40. Therefore, the 
previous studies are unrepresentative of the biggest contributor of habitual 
sugar intake in adolescents (Loader et al., 2017), and fail to identify the acute 
effects of SSB consumption on vascular function. Recent research which has 
assessed the effects of 600 mL of commercial SSB consumption on macro- and 
micro- vascular function compared to a control trial (600 mL of water) in healthy, 
sedentary adult males (Loader et al., 2017). FMD and the microvascular 
response to acetylcholine iontophoresis were significantly lowered following 
consumption of the SSB when compared to the control trial. These findings 
provide an insight into the consequences of SSB consumption on vascular 
function. However, there is currently no data on the effects of commercially 
available SSB on vascular function in youth. 
2.3.1 Fructose and cardiovascular risk 
Fructose, high-fructose corn syrup and sucrose have been introduced to the 
diet and sucrose accounts for >90% of nutritive sweetener consumed worldwide 
(Rippe & Angelopoulos, 2015; White, 2008). Epidemiological studies have 
demonstrated that these sugars, independent of glucose, are associated with 
CVD risk factors including obesity, elevated lipid production and high blood 
pressure in youth and adulthood (Johnson et al., 2009; Bray, 2012; Vartanian et 
al., 2007; Bray, 2010). Fructose is known to increase hepatic VLDL output due 
to the conversion of fructose to triacylglycerol (TAG) by a process known as de 
novo lipogenesis (Stanhope et al., 2009). VLDL are lipoproteins which contain 
TAG and cholesterol (Goldstein & Brown, 2015) and are hydrolysed into LDL, 
which play a key role in the atherosclerotic process (Brown & Goldstein, 1986). 
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Research has shown that the fractional rate of de novo lipogenesis in humans 
for glucose is 2% but for fructose this increases to 10% following 6 days of high-
fructose feeding (Schwarz et al., 2009; Faeh et al., 2005). Stanhope et al. 
(2009) found that de novo lipogenesis was increased to 17% following fructose 
feeding in adults. When glucose and fructose are consumed simultaneously, 
more fructose undergoes the hepatic lipogenic pathway, which results in the 
rate of de novo lipogenesis being tripled as opposed to when fructose is 
consumed independently (Hudgins et al., 2011). Therefore, it is by this 
mechanism that smaller, but daily, intakes of fructose might be bad for health. 
The only study in the meta-analysis by Loader et al. (2015) which included a 
combined sucrose and glucose challenge (39.1 g total) found that microvascular 
function was increased in adults (Grasser et al., 2014). The meta-analysis 
provided no study which examined the effects of a sucrose drink on 
macrovascular function but did report one study which demonstrated a fall in 
FMD in type 2 diabetic adults following consumption of a sucrose test meal 
(Shige et al., 1999). Thus, further research is required to explore the effects of 
sucrose and fructose on the vasculature to provide an accurate understanding 
of the effects of habitual SSB consumption on vascular and metabolic 
outcomes. 
There is limited research examining the effects of fructose on vascular function 
however, a study which examined the influence of consumption of a sucrose 
load representative of that found in commercially available SSBs found that 
there was no change in microvascular reactivity in healthy young adults (West 
et al., 2019). This is not reflective of previous research where Loader et al. 
(2017) used an SSB which contained equal parts of fructose and glucose to 
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determine that SSB consumption also reduced FMD and microvascular function 
in adults. 
Despite the limited and contrasting research exploring the effects of fructose 
consumption on vascular function in adulthood and the lack of research into the 
effects of fructose in youth, rodent data has provided an insight into the effects 
of fructose on metabolic and vascular responses. A systematic review of 26 
studies into the effects of fructose consumption on rats determined that 
consumption of 10-21 mL of fructose per 100 mL of SSB increased rodent body 
weight, systolic blood pressure and blood [glucose], [insulin] and [TAG] (Toop & 
Gentili, 2016). A study which compared the effects of fructose consumption to 
glucose consumption in rats found that fructose consumption increased [TAG] 
and impaired endothelial function but glucose consumption did not (Sanguesa 
et al, 2017). In the same study both fructose and glucose impaired insulin 
signalling which resulted in glucose not being metabolised and converted into 
fat via de novo lipogenesis however, the impairment was greater in the fructose 
group.  
Further research has demonstrated that high-fructose corn syrup feeding 
attenuated expression of insulin receptor substrate-1, endothelial NO synthase 
mRNA and protein, aortic NO and endothelial relaxation (Babacanoglu et al., 
2013; Akar et al., 2012) which results in an increase in synthesis of glucose in 
the liver and vascular dysfunction. Fructose consumption has also been 
determined to increase insulin, total cholesterol and blood pressure as well as 
the expression levels of inducible NO synthase mRNA and protein (Malakul et 
al., 2018; Babacanoglu et al., 2013; Akar et al., 2012) which has been 
associated with impaired insulin signalling in the livers of diabetic mice 
(Fujimoto et al., 2005) and endothelial dysfunction in diabetic rats (Nagareddy 
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et al., 2005). More recently, a study determined that 2 months of high-fat and 
high-fructose feeding in rats increased body weight, leptin, oxidative stress in 
plasma and in the liver and after 8 months induced endothelial dysfunction 
(Lozano et al., 2016). 
Given the findings shown in rodent data and that existing OGTT data is not 
representative of habitual sugar consumption it is important to explore whether 
fructose consumption induces similar vascular and metabolic responses in 
youth.  
2.3.2 Fructose and uric acid 
Fructose-rich beverage consumption is known to increase [uric acid] when 
compared to a control trial (Choi et al., 2008). As the body breaks down 
fructose, chemical compounds called purines are released and uric acid is 
produced during purine metabolism which also generates oxidants and in 
humans this is the final end product of purine metabolism (Johnson et al., 
2013). The normal range for [uric acid] in humans is usually 3 to 7 mg/dL in the 
blood and this is increased by consumption of purine rich foods or fructose 
(Johnson et al., 2013).  [Uric acid] has been associated with CVD in high risk 
groups and healthy populations. A five year follow up study assessed [uric acid] 
and cardiovascular events in healthy men and women (Kivity et al., 2013). In 
this study, [uric acid] was found to be an independent predictor of 
cardiovascular events in both men and women. This study also found that 
fructose consumption was positively associated with an increase in [uric acid] 
when they compared those that consumed more than 75 mg per day to those 
that consumed less than 10 mg per day. Furthermore, [uric acid] did not 
increase following “diet” SSB consumption (no sugar) demonstrating that the 
fructose element of these drinks are what causes the increase in [uric acid]. An 
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in vivo study which fed rats a 60% fructose diet for 10 weeks found that [uric 
acid] was elevated when compared to a control group (Nakagawa et al., 2006). 
A more recent study using rats administered a single dose of fructose (5 g per 
kg) where it was determined that fructose consumption inhibited functioning of 
ileac uric acid excretion which resulted in hyperuricemia (Kaneko et al., 2017). 
Another study fed overweight and obese adults fructose-sweetened beverages 
for 10 weeks (25% of energy requirements) and compared this to a glucose trial 
(Cox et al., 2012). Fasting plasma [uric acid] increased in both groups however, 
the increase was greater in the fructose trial. The findings from these studies 
demonstrate that fructose consumption causes hyperuricemia and that this may 
be due to an inhibition in uric acid excretion.  
A study which assessed CVD risk factors in ~1100 men and women with 
diabetes aged 45 to 64 years calculated hazard ratios for [uric acid] (Lehto et 
al., 1998). It was found that for every 1.01 mg/dL increase in [uric acid] the 
hazard ratio for all-cause mortality was 1.09 for men and 1.26 for women and 
for cardiovascular mortality the hazard ratio was 1.19 for men and 1.3 for 
women, respectively. Further research which followed ~13000 participants from 
the Multiple Risk Factor Intervention Trial (MRFIT) for 6.5 years determined that 
[uric acid] was an independent risk factor for myocardial infarction (Krishnan et 
al., 2006).  
Further research has contradicted the role uric acid plays in CVD risk and CVD 
mortality. The Framingham Heart Study followed ~6700 men for 23 years for 
[uric acid] and incidence of CVD events, CVD deaths and all other deaths 
(Culleton et al., 1999). This study concluded that uric acid does not cause CVD 
death but is associated with other CVD risk factors. The Bogalusa Heart Study 
assessed [uric acid] in ~570 children aged 5 to 17 years and reassessed these 
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participants during adulthood ~12 years later and found that childhood [uric 
acid] was predictive of diastolic and systolic blood pressure in adulthood (Alper 
Jr et al., 2005). A recent study demonstrated that elevated [uric acid] in 
asymptomatic, prepubertal children was associated with several CVD risk 
factors including elevated insulin resistance, C-reactive protein, [TAG], BMI, 
waist circumference, systolic blood pressure and cIMT (Bassols et al., 2016). 
Another study found that for every 1 mg/dL increase in [uric acid] the risk of 
prehypertension or hypertension increased by at least 50% for 6 to 18 year olds 
(Viazzi et al., 2013).  
Research has demonstrated that increased fructose consumption causes an 
increase in [uric acid]. Although it is suggested that uric acid is not a direct 
cause of CVD it is independently associated with CVD in adults and has been 
associated with CVD risk factors in youth. Thus, it is important to explore the 
effects of fructose consumption on [uric acid] in adolescents to provide a clearer 
insight into CVD risk in this population. 
2.4 Postprandial lipaemia and cardiovascular disease 
Previous research has demonstrated that elevated plasma [TAG] is an 
independent risk factor for CVD (Hokanson & Austin, 1996; Patel et al., 2004; 
Sarwar et al., 2007). However, these studies have assessed plasma [TAG] in 
the fasted state when approximately 18 hours of the day is spent in the 
postprandial state (Jackson et al., 2012) making these observations unreflective 
of daily living. Elevated postprandial [TAG] impairs the endothelium which 
makes the arterial wall vulnerable to penetration by the remnants of TAG carrier 
chylomicrons which results in subsequent endothelial dysfunction (Proctor & 
Mamo, 2003). This subsequently leads to the progression of atherosclerotic 
lesions with the lipid constituents to which they’re associated (Jackson et al., 
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2012). Furthermore, atherosclerosis is considered to be a postprandial 
phenomenon (Zilversmit, 1979; Kolovou et al., 2005). Postprandial lipaemia is 
the term given to the consequence of consuming a high amount of fat and this 
is associated with CVD (Boquist et al., 1999). Previous research has 
demonstrated a relationship between postprandial lipaemia and atherosclerosis. 
One study which assessed cIMT 2 hours following an oral fat tolerance test 
demonstrated a significant relationship between postprandial [TAG] and an 
elevated cIMT (Boquist et al., 1999). Another study found that cIMT and 
postprandial [TAG] following consumption of a controlled breakfast were 
significantly correlated (Ahmad et al., 2005). It is suggested that plasma [TAG] 
following consumption of a high-fat meal is a better marker of metabolic health 
and CVD risk than fasting [TAG]. A previous study compared postprandial 
plasma [TAG] between the healthy sons of men with coronary artery disease 
and the healthy sons of healthy men (Uiterwaal et al., 1994). Although fasting 
[TAG] between the groups were similar, postprandial [TAG] was elevated 
significantly more in the sons of coronary artery disease patients suggesting 
that postprandial [TAG] provides a better reflection of metabolic health and 
future CVD risk than does fasting [TAG]. Importantly, data has also 
demonstrated that non-fasting [TAG] determined in the early years can 
independently predict CVD related events in later life. The Copenhagen City 
Heart Study conducted a ~30 year follow up of ~14000 men and women aged 
20 to 93 years and assessed baseline levels of non-fasting [TAG] and other 
CVD risk factors and the incidence of ischemic stroke (Freiberg et al., 2008). Of 
the 14000 participants, ~1600 participants developed ischemic stroke and the 
findings determined that the cumulative incidence of ischemic stroke was higher 
with increasing non-fasting [TAG]. Morrison et al. (2009) conducted 22 to 31 
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year follow up studies in schoolchildren to assess paediatric and adult body 
mass and lipids in those that did and did not suffer a CVD event. This paper 
found that childhood plasma [TAG] was consistently and independently 
associated with CVD in early adulthood. Those which suffered from a CVD 
event also had higher levels of plasma [TAG] during childhood and in early 
adulthood. These findings display the association between [TAG] in the earlier 
years and CVD in later life.  
Previous investigations in adolescents have used a high-fat meal to induce 
postprandial lipaemia and as this occurred a fall in FMD was observed 
(Sedgwick et al., 2013a; Sedgwick et al., 2013b; Sedgwick et al., 2015) and 
microvascular function (Bond et al., 2015a). This attenuation in vascular 
function has been supported by adult data which demonstrated a fall in 
endothelial function in men following consumption of a high-fat meal (Tyldum et 
al., 2009). A previous study assessed the effects of glucose, sucrose and 
fructose consumption on lipaemia following the consumption of a meal 
containing 40 g of fat (Cohen & Schall, 1988). It was found that although there 
was no difference in postprandial lipaemia between glucose consumption with 
the meal (2.11 mmol.L-1·7h-1) and the meal alone (2.42 mmol.L-1·7h-1), 
consumption of sucrose (3.77 mmol.L-1·7h-1) and fructose (4.23 mmol.L-1·7h-1) 
prior to the meal increased postprandial lipaemia compared to the meal alone. 
Thus prior feeding of fructose augments postprandial lipaemia and this may be 
due to an increased rate of de novo lipogenesis as a result of prior fructose 
feeding. It is important to understand the effect of prior sugar feeding from SSBs 
has on postprandial lipaemia and vascular function for results to be reflective of 
the dietary lifestyle of adolescents in the UK. 
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2.5 Reliability of macro- and micro- vascular measurements 
There have been several studies which have examined the reproducibility of the 
FMD technique but many of these use a wide variation in adherence to FMD 
guidelines (Thijssen et al., 2019). Ghiadoni et al. (2012) pooled the results of 
studies which strictly followed FMD guidelines and determined that the FMD 
assessment was highly reproducible with a coefficient of variation of 11.6 to 
16.1%. However, adherence to FMD guidelines is not enough to eliminate for all 
sources of error and the FMD technique is known to be operator dependent 
(Thijssen et al., 2019). Therefore, it is necessary for the reliability of the 
operator performing the FMD protocol to be assessed in this thesis. There is 
only one known study which has assessed the between-day and within-day 
reliability of the FMD assessment in adolescents (Bond et al., 2016). This study 
reported a coefficient of variation (CV) of 10.6 and 5.1% for between-day and 
within-day reproducibility, respectively. Recent guidelines for the FMD 
assessment have recommended that a CV for consecutive FMD scans should 
be <15% (Thijssen et al., 2019). Based on the data from previous paediatric 
and adult studies and recent guidelines this thesis will assess reliability of the 
FMD technique and expect a CV of <15%.  
Previous work by our research group has used laser Doppler imaging for the 
assessment of microvascular function (Bond et al., 2016) which uses a laser 
scanner. The laser Doppler flowmetry technique however, uses probes rather 
than a laser scanner which is likely to be associated with smaller error. 
Therefore, there is a possible advantage to using this technique as opposed to 
other assessments of microvascular function and this thesis aims to determine 
the reliability of this method to inform future investigations. However, the laser 
Doppler flowmetry technique has been considered poorly reproducible but this 
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is most likely attributed to changes in the positioning of the probe (Cracowski et 
al., 2006). To account for the heterogeneity of the microvascular circulation the 
reliability of 2 laser probes rather than 1 will be assessed and the probe location 
on the first scan of each visit will be marked. When the recording site has been 
standardised the reproducibility of post-occlusive hyperaemia has compared 
well with FMD with a coefficient of variation of <10% (Kubli et al., 2000; 
Boignard et al., 2005). A study which assessed the reliability of the laser 
Doppler flowmetry technique to assess post-occlusive reactive hyperaemia 
reported a CV of 38% (Roustit et al., 2010). The only previous paediatric study 
to assess reliability of peak reactive hyperaemia reported a within-day CV of 
11.0% and a between-day CV of 13.3% (Bond et al., 2016). This study also 
reported a within-day CV of 29.9% and a between-day CV of 23.1% for total 
reactive hyperaemia which was consistent with previous research which has 
evidenced a CV of 25.0% for total reactive hyperaemia (Wong et al., 2003). 
Therefore, this thesis aims to report a CV for peak reactive hyperaemia and 
total reactive hyperaemia which is consistent with the literature. 
Thesis Aims 
The work in this thesis aims to determine the effects of sugars found in 
commercially available SSBs on vascular and metabolic outcomes in 
adolescents. In order for the findings to be reliable and valid the reproducibility 
of the macro- and micro- vascular methods of assessment are needed to be 
examined. Therefore, Chapter 4 will assess the reproducibility of the FMD and 
laser Doppler flowmetry techniques for the assessment of macro- and micro- 
vascular function, respectively. Following this, Chapter 5 will focus on the 
effects of sugars found in commercially available SSBs on the macro- and 
micro- vasculature and on plasma [glucose], [lactate], [uric acid] and [TAG] in 
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the acute phase following drink consumption and in the postprandial phase 
following consumption of a high-fat, high-sugar test meal. Due to time 
constraints and the fine detail required for FMD assessment this thesis will only 
explore the effects of sucrose and water (control) on FMD. Sucrose is the main 
sugar constituent of commercially available SSBs (Loader et al., 2017) thus this 
sugar was chosen as findings for FMD would be applicable to the diets of 
adolescents in the UK. Furthermore, only 10 of the 22 subjects will be assessed 
for FMD due to these reasons. However, assessment of microvascular function 
will be performed for all sugar trials and in all subjects.  
1. To determine the reliability of the FMD and laser Doppler flowmetry 
techniques to determine macro- and micro- vascular function, 
respectively (Chapter 4). 
• It is hypothesised that the reliability of these outcomes will be 
consistent with findings from previous reliability studies for the 
assessment of macro- and micro- vascular function. 
2. To determine the effects of glucose, fructose and sucrose consumption 
on acute microvascular function and the effects of sucrose on 
macrovascular function post-drink consumption in adolescents (Chapter 
5).  
• It is hypothesised that glucose, fructose and sucrose will impair 
microvascular function compared to water with the greatest 
impairment being from fructose consumption. 
• It is hypothesised that sucrose consumption will impair 




3. To establish the effects of glucose, fructose and sucrose consumption on 
metabolic outcomes (plasma [glucose], [lactate], [TAG] and [uric acid]). 
• It is hypothesised that consumption of all these sugars will 
increase plasma concentrations of plasma [glucose], [lactate], 
[TAG] and [uric acid].  
• It is hypothesised that there will be a dose response increase in 
uric acid which is proportional to the fructose content of the drinks. 
4. To distinguish the effects of sucrose, fructose and glucose on 
postprandial microvascular function and metabolic outcomes following 
consumption of a high-fat, high-sugar test meal challenge and the effects 
of sucrose consumption on postprandial macrovascular function.  
• It is hypothesised that the high-fat, high sugar test meal will 
attenuate macrovascular and microvascular function. 
• It is hypothesised that the high-fat, high sugar test meal will 
increase postprandial TAG. 
• It is hypothesised that the prior feeding of fructose and sucrose 
will elevate postprandial [TAG] more than the glucose and control 
trials and this will manifest into a proportionately greater reduction 









Chapter 3: Methodology 
3.1 Ethics and informed consent 
Ethical approval for the work contained in this thesis was granted by the 
University of Exeter’s Sport and Health Sciences Ethics Committee 
(171206/B/07). Participants were recruited from a local school in Exmouth, 
Devon with the consent of the Head Teacher and the Physical Education 
department. Details of the study were presented during an assembly to the 
pupils and those which were interested were provided with a participant 
information pack which included a detailed explanation of the study aims, 
experimental procedures, the potential benefits and risks of taking part and the 
participants’ right to withdraw from the study at any point without any adverse 
consequence. The pack also contained a participant assent form, a parental 
consent form and a standard health screen for child volunteers. Participants and 
their parents were given a 7 day period to ask any questions regarding the 
study and ensure they had a thorough understanding of what the study entailed. 
Parents and participants confirmed their desire to be involved in the study by 
signing and returning these forms to the school contact. A follow up telephone 
call was also made to the parents to clear up any uncertainties and for them to 
ask any questions they had regarding the study. Health and safety guidelines 
established by the Sport and Health Sciences department for all testing 
procedures were followed at all times by the research team. All members of the 
research team held valid and in date Disclosure and Baring Service (DBS) 
certificates. Two DBS checked members of the research team were with 
participants at all times from the moment they were picked up from school up 
until they were returned to school. Three members of the research team were 
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first aid trained and emergency contact details for all participants were also 
available at all times. 
3.2 Participants 
Following discussion and authorisation with the teachers, participants were 
recruited via a presentation during a school assembly to ~400 children aged 13 
to 14 years old in the Exmouth, Devon area. Using G* Power (3.9.1.2) 
calculation, based upon a power of 0.8, alpha level of 0.05, between-day 
repeatability of our main outcome (FMD) of R=0.78 (Bond et al., 2016) and a 
partial eta squared effect size of 0.05, a sample size of 32 participants was the 
objective for this study. Children were allowed to ask any questions and 
address any queries they had regarding the study following the assembly. 
Approximately 100 pupils were interested in the study and were provided with 
an information pack to take home to their parents/guardians to discuss their 
involvement in the study. Thirty-one packs were returned with participant 
assent, parental consent and health screening forms completed and signed. 
Three of these participants withdrew themselves and a further four were not 
given authorisation to take part in the study due to school behavioural issues. A 
further three were withdrawn from the study due to availability or no longer 
wishing to take part in the study leaving a final sample size of 22. Exclusion 
criteria included any known cardiometabolic diseases, contraindications to 
exercise, food allergies or the use of any supplement or medication which can 
influence blood vessel function or plasma [glucose] or [TAG].  
3.3 Experimental overview 
Participants visited the laboratory on five separate occasions. One of these 
visits was a preliminary visit to familiarise participants to the testing equipment 
and procedures and to obtain anthropometrical and cardiorespiratory fitness 
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data. The following four visits were experimental visits and all visits were 
separated by approximately one week, with study completion achieved within 
six weeks. The study followed a repeated measures design, with 
counterbalanced trial and the drinks were delivered to the subjects in a double 
blind manner. Prior to every visit participants were transported by car to the 
laboratory by two DBS checked members the research team in a 12 hour fasted 
state and having not completed any structured exercise in the 24 hours prior to 
arriving at the laboratory. The effects of glucose, fructose and sucrose on 
vascular function compared to a control trial (water) before and after 
consumption of a high-fat, high-sugar challenge meal were assessed. A double-
blinded repeated measures design was used. The amount of sugar provided 
was not scaled to body mass, as performed elsewhere (Dengel et al., 2007), but 
rather made reflective of the sugar load present in commercially available sugar 
sweetened beverages (60 g of sugar). The sugar was mixed with 300 mL of 
water. For the control trial participants were given 300 mL of water without any 
sugar.  
3.4 Preliminary visit: visit 1 
3.4.1 Anthropometry 
Participants were collected from school and driven to the laboratory for 8:00 am. 
Body mass (Hampel XWM-150K, Hampel Electronics Co. Taiwan) and stature 
(Seca stadiometer SEC-225, Seca, Hamburg, Germany) were measured to the 
nearest 0.1 kg and 0.1 cm, respectively, using standard procedures. From these 
values BMI was then calculated. Age- and sex-appropriate BMI cut off values 
(Cole et al., 2000) were used to define whether participants were normal weight, 
overweight or obese.  
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Body fat percentage was estimated with BodPod (Body Composition System, 
Life Measurement Instruments, Concord, California, USA). The air displacement 
plethysmography technique was used as it a valid measure of adipose tissue in 
children and adolescents (Winsley et al., 2005). Two measurements of air 
displacement were performed and if the difference between measurements was 
more than 150 mL in body volume, a third measurement was taken. An average 
of the closest two measurements was taken. Equipment was calibrated in 
accordance with the manufacturer’s guidelines with the use of a cylinder of 
specific volume (49.887 L). Participants wore a swimsuit and swim cap to 
minimise error of air trapped in clothes and hair and were weighed on the 
BodPod calibrated digital scale before entering the BodPod chamber. They 
were then instructed to remain seated at all times and to breathe normally. The 
body volume mean was obtained using the manufacturer’s recommendations 
(McCrory et al., 1995) and this value was integrated into the calculation of lung 
volume. Total body fat mass was calculated using the appropriate Siri equation 
(Siri, 1993). The validity of the air displacement plethysmography technique has 
been determined in a study which assessed the method against dual energy x-
ray absorptiometry in tracking changes in body composition before and after a 
16 month weight loss program in adult women (Minderico et al., 2006). The 
findings determined a significant correlation between the methods of 
assessment for change in body fat percentage with a R of 0.76.  
Tanner stage measurement of maturity (Tanner, 1962) was determined by the 
self-assessment of secondary sex characteristics (pubertal hair). This required 
participants to look at scientific drawings depicting 5 stages of pubertal 
development (Morris & Udry, 1980) and to identify which stage best describes 
their own development before sealing this information into an envelope. This 
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method was used due to its validity in paediatric research (R=0.60) (Morris & 
Udry, 1980) and the simplistic and practical nature of the method.  
3.4.2 Peak oxygen uptake and gas exchange threshold  
Peak oxygen uptake (VO2 peak) was determined by an incremental ramp test 
using an electronically braked cycle ergometer (Lode Excalibur Sport, 
Groningen, the Netherlands). VO2 peak was used to characterise the sample 
population to reflect the health status of the participants. Participants 
maintained a cadence of 70-80 revolutions per minute (rpm) throughout the 
warm up (unloaded) and during the incremental ramp test. The ramp rate was 
set at 25 W min-1 in order to elicit fatigue within 8-12 minutes (Buchfuhrer et al., 
1983). Exhaustion was characterised as a drop below 60 rpm in cadence for 5 
consecutive seconds despite strong verbal encouragement. This was followed 
by a 5 minute cool down at 20 W. 
Pulmonary oxygen uptake (V̇O2) and carbon dioxide production (V̇CO2) were 
assessed throughout the incremental ramp test using a Medgraphics metabolic 
system (MedGraphics, UK, Ltd), which was calibrated using standard calibration 
gas (15.1% O2, 5% CO2) and a 3.0 L calibration syringe (Hans Rudolph, USA) 
prior to each test. Peak power output was defined as the highest work rate 
achieved during the ramp test. Peak V̇O2 (?̇?O2peak) was determined as the 
highest 10 s average in V̇O2 elicited during the ramp test (Barker et al., 2011). 
Although the current thesis did not use a supramaximal verification test, the 
ramp test to exhaustion is shown to provide a ‘true’ measurement of oxygen 
uptake in ~90% of adolescents in our laboratory (Sansum et al., 2019; Barker et 
al., 2011). Due to unavailability, one of the 22 participants was unable to carry 
out the ramp test. Age- and sex- appropriate ?̇?O2 max cut off points were used to 
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define low fitness as this is an accurate tool for screening children for clustering 
of CVD risk factors (Adegboye, 2011). The cut off points were 33.0 and 
46.0ml/min/kg for 15-year-old girls and boys, respectively. 
3.5 Experimental visits: visits 2-5 
3.5.1 Baseline measurements 
A protocol schematic for the experimental visits is provided in Figure 3.5.1.2. 
Upon arrival to the laboratory at 8:00 am, participants rested for 30 minutes in 
the supine position in a temperature controlled room (24°C). Following the 30 
minutes of rest FMD and microvascular function were simultaneously assessed 
and a baseline capillary blood sample for plasma [glucose], [lactate], [uric acid] 
and TAG was taken.  
3.5.1.1 Sugary drink consumption 
Participants were then given a sugary drink (glucose, fructose or sucrose) or 
control (water) to consume in 10 minutes. For the following two hour period 
blood samples for plasma [glucose], [lactate] and [uric acid] were taken every 
30 minutes. The final sample was also assessed for plasma [TAG] to align with 
the known peak in postprandial lipaemia (Bond et al., 2015b). The simultaneous 
assessment of FMD and microvascular function was repeated one hour 
following drink consumption to coincide with the expected peak in 
hyperglycaemia and uric acid concentrations (Bidwell et al., 2010).  
3.5.1.2 High-fat meal challenge 
Participants then consumed a standardised high-fat, high-sugar test meal (60 g 
fat + 45 g sugar, 1316 kcal) two hours following sugary drink consumption. The 
meal included pizza (Chicago Town® four cheese pizza, 310 g), ice cream 
(Essential Waitrose® soft scoop vanilla ice cream, 125 g) and a chocolate 
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pudding (Cadbury® milk chocolate sticky puds, 95 g). The macronutrient 
composition of this meal was selected as it has previously been shown to cause 
an impairment in vascular function in adolescents (Bond et al., 2015d). 
Following consumption of the meal, capillary blood samples for plasma 
[glucose], [lactate] and [uric acid] were taken every 60 minutes for the following 
three hours with the final sample also being assessed for [TAG]. The 
simultaneous assessment of FMD and microvascular function was performed 
three hours after consumption of the test meal to coincide with the elevation in 
plasma [TAG] in the postprandial period (Bond et al., 2015d). FMD assessment 
was performed for the control and sucrose trials only but microvascular 
assessment was performed for all trials as sucrose represents the sugar found 
in commercially available SSBs (Loader et al., 2017) and due to time 







Figure 3.5.1.2. Protocol schematic. FMD: flow mediated dilation (for control & sucrose trials only) and microvascular 




3.5.2 Assessment of macrovascular function 
Macrovascular function of the brachial artery was assessed via FMD in line with 
contemporary guidelines (Thijssen et al., 2019; Thijssen et al., 2011) The FMD 
technique is a widely used, noninvasive ultrasound technique which examines 
the change in brachial artery diameter to an increase in blood flow (Meyer et al., 
2006). The increased blood flow is stimulated following temporary limb 
occlusion for a period of ~5 minutes (Ras et al., 2013). To ensure that FMD is 
NO-dependent, to reflect NO-mediated vascular function, the cuff is positioned 
distal to the ultrasound probe and inflated for a period of 5 minutes (Thijssen et 
al., 2019; Thijssen et al., 2011). A strong body of evidence indicates that FMD 
independently predicts future cardiovascular events in populations at risk of 
CVD (Inaba et al., 2010; Ras et al., 2013; Matsuzawa et al., 2015). 
Furthermore, a study which assessed FMD in coronary artery disease patients 
found that FMD explained 62% of the variance in coronary artery function 
(Takase et al., 1998). It was also determined that the vasodilator response of 
the coronary and brachial arteries when administered with acetylcholine were 
closely related in individuals with and without coronary artery disease (Takase 
et al., 2005). These findings suggest that FMD is an important marker of 
endothelial function, indicative of vascular health beyond the brachial artery, 
and can be readily applied for paediatric use as it is non-invasive. 
FMD was expressed as the percentage increase from baseline diameter to 
peak diameter. This method of assessment of brachial artery vasodilation has 
come under scrutiny due the dependency of this outcome on baseline diameter 
(Atkinson & Batterham, 2012; Atkinson & Batterham, 2013; Atkinson et al., 
2009). It has been shown that participants with a wider baseline arterial 
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diameter will have a lower FMD statistic than those with a lower baseline 
diameter as FMD is inversely correlated with baseline diameter (Thijssen et al., 
2008; Celermajer et al., 1992). Although, this ratio-scaling method of 
assessment for FMD has been questioned due to the influence of baseline 
diameter not being adjusted for (Packard & Boardman, 1999) it has been shown 
to independently predict future CVD events (Brevetti et al., 2003; Gokce et al., 
2002; Gokce et al., 2003; Meyer et al., 2005) whereas the allometric-scaling 
method of assessment for FMD does not (Atkinson & Batterham, 2015). 
The imposed shear stimulus also effects the magnitude of change in artery 
diameter (Pyke et al., 2004). This is influenced by many factors and has a high 
variability between individuals (Joannides et al., 2002; Mitchell et al., 2004; 
Pyke et al., 2004). If shear and FMD are related FMD is required to be 
normalised for shear in order to determine whether low FMD values are due to 
an unhealthy endothelium or due to low shear (Harris et al., 2010; Pyke & 
Tschakovsky, 2007; Thijssen et al., 2011). It has been reported that there is no 
relationship between FMD and shear in paediatric populations where it was 
found that shear explained only 2% of the variance in FMD (Thijssen et al., 
2009). FMD and SRAUC data obtained for this thesis determined that there was 
no relationship between these two outcomes (R=0.12, P=0.48). Despite this, it 
is recommended by current guidelines to report the shear stimulus although it is 
inappropriate to normalise FMD for shear if the variables are not related 
(Thijssen et al., 2011).  
The diameter of the brachial artery was measured using high resolution 
ultrasonography (Sequoia 512, Acuson, Siemens Corp, Aspen, USA) in duplex 
mode with a 13 MHz linear array transducer. Once the image of the luminal-
arterial wall was optimised the transducer was clamped in place. B mode 
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images of the brachial artery in longitudinal section were captured at a 
reproducible point in the upper arm. Doppler velocity was assessed using an 
insonation angle of 60o with the gate as wide as possible without making 
contact with the vessel walls (Thijssen et al., 2019; Thijssen et al., 2011). The 
gate size was noted and scanning location was marked using a pen for each 
participant and replicated for all assessments as demonstrated in Figure 3.5.2. 
 
Figure 3.5.2. Flow-mediated dilation ultrasound scan of brachial artery. PW 
Gate: size of gate in mm which was repeated for all assessments for that 
participant.  
Baseline diameter of the artery was assessed for 60 s followed by the rapid 
inflation of a pneumatic cuff (Hokanson, Bellevue, USA) to 220 mmHg. The cuff 
remained inflated for 5 minutes before rapid (<0.3 sec) deflation and during this 
period arterial diameter and blood flow were not assessed. Arterial diameter 
and blood flow was measured for a further 3 minutes following occlusion. During 
cuff occlusion arterial diameter and blood flow was not measured. The primary 
investigator performed all FMD analyses and was blinded to the trial. Arterial 
Gate size which was 
replicated for all 
assessments 
Location of brachial 
artery which was 





diameter was determined during end diastole using validated ECG-gating 
software (R=1.0) (Medical Imaging Applications LLC, Coralville, USA) (Mancini 
et al., 2002). Diameter change was determined using the equation as described 
in Equation 1 and shear rate using the equation as described in Equation 2 for 
the period between cuff deflation and peak arterial diameter (Harris et al., 
2010). The total shear stimulus (SRAUC) was determined as the area under the 
shear curve versus time from the moment the cuff was released until diameter 
peak was reached (Pyke and Tschakovsky, 2007).  
Diameter change (%) = ((Peak diameter/Baseline diameter) x 100) – 100 
Equation 1. Calculation of diameter change 
Shear rate = (8 x mean blood velocity)/artery diameter 
Equation 2. Calculation of shear rate 
3.5.3 Assessment of microvascular function 
Microvascular function of the cutaneous circulation was assessed throughout 
the FMD protocol in both chapters via the Doppler flowmetry (LDF) technique 
(MoorVMS-LDF, moor instruments Ltd, UK). Two low power laser probes were 
attached onto a reproducible point of the distal third of the left forearm using 
moulded flexible sockets and secured adhesive discs. When placing the probes 
freckles, scars and hairs were avoided and the area of placement was marked 
with a pen for reproducibility. The assessor drew around each of these probes 
after the first scan to best replicate their location to minimise error. A red laser 
beam (785 nm) was used at a power of 2.5 mW for the assessment of 
cutaneous blood flow using the Doppler principle. Red blood cell velocity and 
concentration was then used to calculate flux in perfusion units (PU) by the 
Moor Instruments Vascular Monitoring System. Raw microvascular data for both 
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probes were visually inspected and the data across the 2 probes were averaged 
prior to further handling. Data was then converted into 1 second averages and 
baseline microvascular data was assessed and averaged for the first 60 s of the 
FMD protocol prior to 5 min of cuff occlusion. The peak value was taken as the 
highest value obtained following cuff deflation. Peak reactive hyperaemia (PRH) 
was determined using the highest value following cuff deflation and expressing 
this as a percentage of baseline perfusion. The total hyperaemic response 
(TRH) was expressed as described in Equation 2. When determined in this 
manner, the TRH outcome does not reflect an NO-dependent pathway (Wong 
et al., 2003).  
 
Total hyperaemic response = Area under the post-occlusive curve – baseline 
blood flow (% maximal cutaneous vascular conductance) x time taken for 
reactive hyperaemia to return to baseline 
Equation 2. Total hyperaemic response (TRH) (Wong et al., 2003). 
3.6 Bloods analyses 
During the experimental visits fingertip capillary blood samples were taken 
before and 30, 60, 90 and 120 minutes after consumption of test drinks using a 
safety lancet (Sarstedt Ltd., Leicester, UK) for analysis of plasma [glucose], 
[lactate] and [uric acid]. The first and final blood sample was also analysed for 
[TAG]. This was repeated at 60, 120 and 180 minutes following consumption of 
the standardised test meal for assessment of [glucose], [lactate] and [uric acid]. 
The final blood sample (180 minutes post-meal) was assessed for [glucose], 
[lactate], [uric acid] and [TAG]. Each blood sample (<1 mL) was collected into 
heparin coated microvette tubes (CB 300 tubes, Sarstedt Ltd., Leicester, UK) 
50 
 
and immediately centrifuged at 13000 g for ~15 minutes at 4oC. Plasma was 
then stored at -80oC or analysed immediately for [glucose] and [lactate] 
simultaneously (YSI 2300 Stat Plus Glucose analyser, Yellow Springs, OH, 
USA). [TAG] was assessed in capillary whole blood in line with the 
manufacturer’s instructions (CardioChek; Polymer Technology Systems). [Uric 
acid] was assessed using whole blood from a single sample using a portable 
uric acid meter for which the manufacturer’s reported a correlation coefficient of 
0.97 for the reliability of the testing meter against an accepted laboratory 
analyser (UASure, Apex Biotechnology Corp., Hsinchu, Taiwan).  
3.7 Statistical analyses 
All statistical analyses for the current thesis were performed using SPSS 
(version 25.0, Chicago, USA) other than area under the curve (AUC) analysis 
which was performed on GraphPad and calculated area using the trapezium 
rule (Prism 8, GraphPad software, San Diego, California, USA). The pre-drink 
concentration was used as baseline and AUC was determined as the total area. 
All data are presented as mean + standard deviation. Comparisons between 
means for the experimental chapter were also expressed as 95% confidence 
intervals (95% CI) in accordance with current recommendations (Hopkins et al., 
2009). Standardised effect sizes (ES) were determined as the differences in 
means divided by the pooled standard deviation. This is due to recent criticisms 
that the null hypothesis is always false as all effects are statistically significant if 
there is a large enough sample size and that the null hypothesis approach 
inadequately deals with the real-world importance of an effect (Hopkins et al., 
2009). This was used to assess whether the mean change in a variable was 
meaningful using the thresholds recommended by Cohen (1988): small (0.2), 
moderate (0.5) and large (0.8). Effect sizes for the repeated measures ANOVAs 
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used in the experimental chapter were presented as partial eta squared (ηp2), 




















Chapter 4: Reliability Chapter 
4.1 Introduction 
Atherosclerosis is the underlying disease process which precedes subsequent 
CVD and progresses throughout life (Ross, 1999; McGill & McMahan, 2003). 
The early atherosclerotic manifestations which precede overt CVD occur during 
childhood (Stary, 1989), thus the ability to non-invasively detect the originating 
manifestations of the atherosclerotic process during the earlier years is a matter 
of importance for the prevention of CVD (Celermajer et al., 1992). It is important 
to quantify the reliability of these outcomes to determine whether they are 
suitable for use in future interventions with this population and can also inform 
future power calculations.  
The primary stage of the atherosclerotic process is endothelial dysfunction 
which precedes subsequent arterial damage (Tounian et al., 2001; Meyer et al., 
2006). The FMD technique has become the most widely used method of 
assessment for endothelial function in the macrovasculature. This technique 
uses high resolution ultrasound imaging during a protocol in which brachial 
artery vasodilation is determined before and after 5 minutes of forearm cuff 
occlusion to quantify brachial artery function (Bond et al., 2016). Celermajer et 
al. (1992) developed the FMD technique and with it identified that children and 
adolescents present with CVD risk factors demonstrated a lower FMD than 
healthy controls. Paediatric research has since used this technique to measure 
endothelial function in adolescents and has also used this method to assess 
within- and between-day endothelial function in adolescents in interventional 
and observational studies (Bond et al., 2015b; Hopkins et al., 2012).  
The earliest changes in the atherosclerotic process may occur in the capillary 
and arteriole beds and not at the macrovascular level (Pinkney et al., 1997). 
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Furthermore, microvascular function has been shown to predict future 
cardiovascular events when FMD has not (Anderson et al., 2011). There has 
been little association between FMD and post-occlusive reactive hyperaemia 
(microvascular function) in adults in the literature (R<0.09, P>0.05) (Shamim-
Uzzaman et al., 2002; Dhindsa et al., 2008). Therefore, microvascular function 
cannot be inferred from FMD status and the two can be assessed 
simultaneously. A method for which this is done is by measuring the 
hyperaemic response of the peripheral vascular endothelium (cutaneous 
circulation of the microvasculature in the forearm) during the FMD protocol 
following cuff occlusion (Bond et al., 2016). Microvascular function has been 
determined by measuring cutaneous perfusion in response to forearm cuff 
occlusion in adolescents (Bond et al., 2016). However, this study used laser 
Doppler imaging whereas the current study aims to determine the reliability of 
the laser Doppler flowmetry technique which has been used to assess 
microvascular function in the forearm of adults (Ozbebit et al., 2004; Farkas et 
al., 2004). The reliability of this technique has been assessed in adults (Herron 
et al., 2015) but has not been assessed in adolescents. Therefore, this study 
aims to determine the reliability of this technique in adolescents to distinguish 
whether this technique is suitable for use in Chapter 5. 
These assessments are usually performed separately but the between- and 
within-day reliability of simultaneously performing assessments of FMD and 
microvascular function in adolescents has been examined (Bond et al., 2016). 
The researchers of this recent study concluded that a single protocol can be 
used to reliably and non-invasively assess these outcomes in line with current 
guidelines. However, adherence to guidelines for these techniques does not 
determine reproducibility and operation of the FMD technique is operator 
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dependent (Thijssen et al., 2019). Additionally, the laser Doppler flowmetry 
technique has been considered poorly reproducible when guidelines are not 
strictly followed (Cracowski et al., 2006) (see section 2.5). This study aimed to 
determine the reliability of the laser Doppler flowmetry technique for 
assessment of microvascular function using two laser probes. Therefore, the 
current study aims to compare the reliability of the data collected as part of this 
thesis against known reliability data to determine whether the operator is 
reliable in assessing FMD and whether the laser Doppler flowmetry technique is 
reliable for assessment of microvascular function in adolescents.  
4.2 Methods 
4.2.1 Participants 
The data in this study was collected from the experimental study in Chapter 5. 
Data was collected from twenty-two healthy adolescents (age: 14.3 ± 0.4 years, 
height: 1.64 ± 0.08 m, mass: 55.1 ± 11.0 kg).  
4.2.2 Study protocol 
Participants visited the laboratory on 4 separate occasions to perform the 
experimental trial on both occasions as outlined in Chapter 5. These visits 
occurred over the course of a 6 week period. Participants arrived at the 
laboratory following a 12 hour overnight fast ready to begin at 8:00 am. 
Participants were rested in a darkened, temperature-controlled (24oC) room for 
5-10 minutes before the assessment of macrovascular (FMD) and 
microvascular function which were performed simultaneously. For the 
assessment of within-day reliability participants consumed 300 mL of water and 
the test was repeated 1 hour after consumption. During the 1 hour period 
participants remained sedentary in the laboratory.  
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4.2.3 Assessment of vascular function 
For FMD and microvascular protocol see 3.5.2 and 3.5.3. Ten of the twenty-two 
participants were assessed for FMD due to time constraints and all twenty-two 
were assessed for microvascular function. 
4.2.4 Statistical analyses 
A mixed model analysis of variance (ANOVA) was used to analyse FMD and 
microvascular function with visit (between-day) or assessment (within-day) as 
the main effects. The reproducibility of these outcomes were expressed by 
using the typical error, typical error expressed as a coefficient of variation (CV) 
and Pearson’s correlation coefficient (r) for within-day assessment and 
intraclass correlation coefficient for between-day assessment (Hopkins, 2000). 
The typical error accounts for the random variation in an individual’s values on 
repeated testing and the coefficient of variation is used to express typical error 
as a percentage of its respective mean to account for the large variability of 
values (Hopkins, 2000). The Pearson’s correlation is appropriate for assessing 
the relationship between 2 trials and the intraclass correlation coefficient is 
unbiased for any sample size and is the most sensible approach to determine 
the correlation for more than two trials (Hopkins, 2000). FMD was not 
normalised for SRAUC as they were not related (R=0.12, P=0.48) which is 
consistent with previous paediatric data (Bond et al., 2016; Hopkins et al., 
2015). Many researchers publish FMD/SRAUC data, so this aids comparison 
across the literature (Bond et al., 2016; Hopkins et al., 2015). Statistical 




4.3.1 Within-day reliability 
No significant differences were apparent between the means for assessments 1 
and 2 for all outcomes (Table 4.3.1). The within-day typical error was 1.07 for 
percentage change in FMD (FMD), 1.25 for PRH and 1.34 for TRH. The within-
day CV was 7.2% for FMD, 24.5% for PRH and 33.7% for TRH. The Pearson’s 












Table 4.3.1. Within-day reproducibility of novel CVD outcomes 
 Assessment 1 Assessment 2 Change in 
mean 
P value Typical error Typical error as CV (%) R 
Baseline 
FMD (mm) 
3.03+0.33 2.97+0.36 -0.06 0.13 1.03 2.9 0.95 
Peak FMD 
(mm) 
3.32+0.36 3.25+0.41 -0.07 0.10 1.03 2.8 0.96 
Ratio-scaled 
FMD (%) 
9.7+2.3 9.5+2.4 -0.2 0.47 1.07 7.2 0.93 
SRAUC 88054+36912 71069+18442 -16984 0.12 1.24 24.4 0.68 
Baseline 
PRH (AU) 
26+5 24+8 -2 0.37 1.32 32.5 0.20 
Peak PRH 
(AU) 
121+21 115+39 -6 0.46 1.27 27.3 0.44 
PRH (%) 477+82 497+141 20 0.55 1.25 24.5 0.18 
PRHt (s) 27+13 26+10 -1 0.86 1.77 77.5 -0.01 
TRH (AU) 11512+2924 11043+4319 -469 0.63 1.34 33.7 0.37 
FMD, flow-mediated dilation. SRAUC, area under the postocclusive curve until peak dilation for shear rate. PRH, peak reactive 
hyperaemia. PRHt, time taken to achieve peak reactive hyperaemia. TRH, total reactive hyperaemia. CV, coefficient of 




4.3.2 Between-day reliability 
No significant differences were apparent between the means for assessments 1, 2, 3 and 4 for all outcomes (Table 4.3.2). The 
between-day typical error was 1.08 for FMD, 1.26 for PRH and 1.33 for TRH. The between-day CV was 8.0% for FMD, 26.1% 





















Table 4.3.2. Between-day reproducibility of novel CVD outcomes. 





3.03+0.33 3.04+0.29 2.99+0.30 3.06+0.33 0.41 1.04 3.7 0.88 
Peak FMD 
(mm) 
3.32+0.36 3.34+0.30 3.27+0.32 3.35+0.38 0.44 1.04 3.8 0.87 
Ratio-scaled 
FMD (%) 
9.7+2.3 9.7+2.7 9.6+3.0 9.8+2.3 0.73 1.08 8.0 0.96 
SRAUC 82858+38850 77268+29947 87156+44435 91555+36298 0.82 1.43 42.6 0.47 
Baseline PRH 
(AU) 
26+5 26+10 24+9 26+9 0.83 1.31 31.2 0.14 
Peak PRH (AU) 121+21 117+29 119+40 115+24 0.92 1.28 27.9 0.40 
PRH (%) 476.50+82.13 477.45+105.61 502.53+137.98 467.55+143.27 0.83 1.26 26.1 0.03 
PRHt (s) 26.68+12.77 28.18+13.33 25.36+13.62 23.68+12.12 0.60 1.70 69.6 -0.07 
TRH (AU) 11512+2924 11514+3714 11215+4563 111137+2848 0.96 1.33 32.7 0.49 
FMD, flow-mediated dilation. SRAUC, area under the postocclusive curve until peak dilation for shear rate. PRH, peak reactive 
hyperaemia. PRHt, time taken to achieve peak reactive hyperaemia. TRH, total reactive hyperaemia. CV, coefficient of 




The key findings of this study were that the within-day CV for the FMD outcome 
was 7.2% and was 24.5 and 33.7% for PRH and TRH, respectively. The 
between-day CV for FMD was 8.0% and 26.1 and 32.7% for PRH and TRH, 
respectively. Early guidelines suggested that a CV of 20-30% was appropriate 
for the reproducibility of the FMD outcome (Corretti et al., 2002). FMD analysis 
software has developed since this publication, resulting in an almost 4-fold 
improvement of the reproducibility of the FMD technique (Woodman et al., 
2001). Accordingly, dedicated analysis software is now recommended in current 
guidelines for the FMD protocol (Thijssen et al., 2019; Thijssen et al., 2011; 
Harris et al., 2010) after the initial findings by Corretti et al. (2002). 
There is only one known paediatric study which has assessed both the within-
day and between-day reproducibility of the FMD protocol (Bond et al., 2016). 
The between-day variability of the FMD outcome in this study replicates early 
findings from our lab (Bond et al., 2016) which used an identical setup and 
reported a CV of 10.6%. The within-day variability of the FMD outcome in this 
study (8.0%) is also consistent with the CV of 5.1% reported in Bond et al. 
(2016) and compares favourably to adult data which reports a CV of 5.8-14.0% 
(Meirelles et al., 2007; Donald et al., 2008; Ghiadoni et al., 2012; Onkelinx et 
al., 2012; Craiem et al., 2007; Beux et al., 2001).  
The between-day CV of 8% for the FMD outcome reported in this study is also 
consistent with the ranges presented by previous studies in adults (9.6-16.1%) 
(Meirelles et al., 2007; Donald et al., 2008; Ghiadoni et al., 2012; Onkelinx et 
al., 2012; Craiem et al., 2007).  
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By following standardised protocols (Thijssen et al., 2019; Thijssen et al., 2011), 
known sources of error were minimised in the current study to minimise known 
protocol- and environmental-based confounders of the FMD outcome, and best 
isolate the physiological variability of macro- and micro- vascular reactivity. The 
findings represent good reproducibility for the FMD outcome and it is thought 
that this is due to following the standardised protocols. All participants were free 
from overt cardiometabolic disease and all scans were assessed by the same 
operator. The CV of 7-8% in the current study could be as a result of 
measurement error as the operator in this study was newly trained at 
performing the method. However, it is more likely that this could be due to the 
small sample size of 10 participants in the current study whereas the previous 
paediatric reproducibility study for the FMD technique used a sample size of 40 
and reported lower CVs for within-day and between-day reproducibility (Bond et 
al., 2016).   
The SRAUC outcome demonstrated poorer reproducibility in this study with both 
a within- and between-day CV of 24.4 and 42.6%, respectively, exceeding the 
values reported by Bond et al. (2016) of 12.0 and 29.6%, respectively. These 
differences are most likely attributed to the difference in sample sizes used in 
the current study and Bond et al. (2016). The current study and previous 
paediatric research has failed to demonstrate a meaningful relationship 
between FMD and SRAUC (Bond et al., 2016; Hopkins et al., 2015; Thijssen et 
al., 2009). This could be as a result of poor variability of the SRAUC outcome 
which renders such a relationship difficult to observe. Normalising FMD for 
SRAUC would therefore be inappropriate and would result in poorer reliability 
within the data for within-day and between-day variation which suggests there is 
not a strong argument for expressing FMD in this manner in a paediatric 
62 
 
population. FMD/SRAUC in the current study demonstrated poor reproducibility 
with a CV of 23.3 and 38.6% for within-day and between-day, respectively. 
These exceed the values reported by Bond et al. (2016) of 12.0 and 25.7% for 
within-day and between-day CV, respectively. Unless a meaningful relationship 
is observed between these two outcomes, the FMD/SRAUC outcome should not 
be included in analysis in paediatric population due to the poor reproducibility of 
this outcome in both these studies. 
This study also assessed microvascular function during the FMD protocol, 
which has been adopted previously (Bond et al., 2016). To minimise for error for 
the microvascular assessment all participants were acclimatised to a 
temperature controlled room as temperature has been demonstrated to affect 
endothelial function (Cracowski et al., 2006). The CV for both within-day and 
between-day TRH in the current study was consistent with the CV of 25.0% in 
Wong et al. (2003) and the within-day CV of 29.9% and between-day CV of 
23.1% reported by Bond et al. (2016). Although the within-day and between-day 
CV for PRH in the current study exceeds the values of 11.0 and 13.3% reported 
in Bond et al. (2016), the between-day CV of the current study was able to 
replicate the findings of another study which assessed post-occlusive reactive 
hyperaemia using laser Doppler flowmetry to determine microvascular function 
(CV of 38.0%) (Roustit et al., 2010). Thus, the variability in the microvascular 
data between the current study and others could be due to the method of 
assessment. Bond et al. (2016) used a laser Doppler perfusion imager whereas 
the current study and Roustit et al. (2010) used laser Doppler flowmetry. As 
laser Doppler imaging uses a laser scanner rather than the probe used in the 
laser Doppler flowmetry technique thus the difference between these methods 
of assessment could explain the differences in reproducibility. The variability for 
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between-day PRH and TRH could also be attributed to the placement of the 
laser probes. Probe location was marked prior to the first scan of each visit 
however was not repeated between-days. It has been determined that the poor 
reproducibility often seen for the laser Doppler flowmetry technique is attributed 
to non-standardisation of the placement site (Cracowski et al., 2006). The 
current study however, does show that the simultaneous assessment of PRH 
and TRH during the FMD protocol is possible using laser Doppler flowmetry. 
Researchers may wish to consider this increased variability when performing 
power calculations for sample sizes. If a sample size for a future study using 
this technique is too small it may struggle to report a significant effect when in 
reality there is one. Further research is required to assess the reproducibility of 
the laser Doppler flowmetry technique in assessing cutaneous perfusion during 
post-occlusive reactive hyperaemia in order to determine boundaries of 
reproducibility for PRH and TRH when assessed in this manner.   
A limitation of this study was that 22 participants were used as opposed to the 
32 recommended by the G*Power calculation. Additionally, only 10 participants 
were assessed for FMD. This could potentially affect our ability to detect true 
change in FMD, PRH, TRH and microvascular function in the experimental 
study in Chapter 5 due to wider variation in the data.  
The current study aimed to distinguish the within-day and between-day 
reproducibility of FMD and laser Doppler flowmetry for the assessment of 
macro- and micro- vascular function, respectively. The findings for FMD are 
consistent with the literature and are reliable. Our findings for microvascular 
reproducibility are consistent with previous research which has assessed the 
reproducibility of laser Doppler flowmetry.  
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Chapter 5: The Vascular and Metabolic Responses to Consumption of 
Fructose, Sucrose and Glucose in the Acute and Postprandial Phase 
5.1 Introduction 
The atherosclerotic process which precedes subsequent CVD originates in 
childhood and progresses throughout life (Ross, 1999; McGill & McMahan, 
2003). Paediatric research has shown that the progression of atherosclerosis in 
childhood and into later life is associated with the clustering of CVD risk factors 
(Farah et al., 2014) and the clustering of CVD risk factors tracks into adulthood 
(Bao et al., 1994; Katzmarzyk et al., 2001). It has been suggested that 
introducing interventions in the first two decades of life to modify CVD risk 
factors are important for the prevention of CVD in later life (McGill et al., 2000a).  
As a result, it is important to tackle CVD risk in these early years as it may delay 
the onset of atherosclerosis and CVD.  
The primary stage of atherosclerosis is endothelial dysfunction (Tounian et al., 
2001; Meyer et al., 2006). It has been shown that asymptomatic children and 
adolescents with CVD risk factors display endothelial dysfunction when 
compared to healthy controls (Celermajer et al., 1992). As endothelial 
dysfunction is prerequisite for subsequent atherosclerosis (Juonala et al., 2004; 
Tounian et al., 2001; Meyer et al., 2006), it is of importance to prevent 
endothelial dysfunction in the early years to delay later structural changes to the 
vessel wall. The FMD ultrasound technique has become the adopted non-
invasive method of assessment for endothelial function in vivo (Thijssen et al., 
2019), and has an inverse association with CVD risk in adults and children (Ras 
et al., 2013; Green et al., 2011; Chan et al., 2003; Tounian et al., 2001; 
Sorensen et al., 1994; Woo et al., 2004).  
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It has also been shown that microvascular function has predicted future 
cardiovascular events when FMD has not (Anderson et al., 2011) and that the 
post-occlusive response in these two vascular beds are unrelated (Shamim-
Uzzaman et al., 2002). Unlike FMD, the post-occlusive microvascular response 
is not NO-mediated (Wong et al., 2003). Thus, assessing microvascular as well 
as macrovascular function may provide important prognostic information which 
cannot be obtained from FMD assessment alone.  
Current guidelines recommend a limit of <25 g per day of added sugar for 
young people (Vos et al., 2017) and sugar-sweetened beverage (SSB) 
consumption is a key contributor to sugar intake. In fact, adolescents in the UK 
aged 11 to 18 years consume 191 g of SSB per day, equating to 22-28 g of 
sugar, which is more than any other group (Public Health England, 2018; Malik 
et al., 2006).  
These statistics are worrying as the consumption of SSBs has been associated 
with an increase in CVD risk factors in youth including dyslipidaemia, insulin 
resistance, future weight gain and hypertension (Vos et al., 2017; Basu et al., 
2013; Ludwig et al., 2001; Chan et al., 2014).  
A recent meta-analysis of 39 studies which assessed the influence of acute 
hyperglycaemia on macro- and micro- vascular function concluded that SSB 
consumption negatively influences vascular function (Loader et al., 2015). 
However, studies which investigated the effects of sugar consumption in 
adolescents have not supported this. These studies used an oral glucose 
tolerance test (OGTT) to assess the vascular response in adolescents which 
were either healthy or obese (Dengel et al., 2007) and with type 1 diabetes (Dye 
et al., 2012) and found no reduction in vascular function and Dengel et al. 
66 
 
(2007) reported a ~2% increase in FMD. However, these studies used an OGTT 
which is not reflective of commercially available SSBs which contain sucrose 
(Loader et al., 2017). Sucrose is made up of equal parts of glucose and fructose 
and these sugars are metabolised differently (Lustig, 2012). Although glucose 
can be metabolised at multiple sites, fructose can only be metabolised by the 
liver and this process is insulin independent (Lustig, 2012). Epidemiological 
studies have demonstrated that consumption of fructose and sucrose is 
associated with cardiovascular risk factors including obesity, elevated lipid 
production, high blood pressure and uric acid concentrations (Johnson et al., 
2009; Bray, 2012; Vartanian, 2007; Bray, 2010; Malik & Hu, 2015). However, 
the influence of glucose, fructose and sucrose on CVD risk factors have also 
not been assessed and/or compared in adolescents.  
Understanding the acute effects of SSB consumption on vascular and metabolic 
responses in the fasted state is useful but limited. It has been shown that prior 
fructose, but not glucose, consumption augments the postprandial lipaemic 
response to high-fat, high-sugar test meal (Cohen & Schall, 1988) and 
postprandial lipaemia has been implicated in the progression of CVD (Boquist et 
al., 1999). Also, endothelial dysfunction has been shown to occur in the 
presence of elevated [TAG] in the postprandial stage (Bond et al., 2015a). It is 
suggested that plasma TAG following consumption of a high-fat meal is a better 
marker of metabolic health and CVD risk than fasting TAG and research 
suggests non-fasting lipid concentrations in the early years is predictive of CVD 
related events later in life (Freiberg et al., 2008; Morrison et al., 2009). 
Therefore, it is also important to determine whether consumption of the different 
types of sugars found in SSBs influence postprandial vascular function and 
lipaemia following a test meal. 
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Fructose consumption has also been associated with elevated uric acid 
production (Nakagawa et al., 2006). This may cause a reduction in endothelial 
function as a result of lowered NO bioavailability and elevated inflammation 
(Nakagawa et al., 2006; Roglans et al., 2007). Elevated [Uric acid] has been 
associated with an increased risk in cardiovascular mortality (Lehto et al., 1998) 
and is also an independent risk factor for myocardial infarction (Krishnan et al., 
2006). Data from the Bogalusa Heart Study has also demonstrated that 
childhood [uric acid] is predictive of diastolic and systolic blood pressure in 
adulthood (Alper Jr et al., 2005). Recent data has also demonstrated that high 
concentrations of uric acid causes a reduction in FMD (Zhen & Gui, 2017) and 
induces endothelial dysfunction in human umbilical vein endothelial cells (Cai et 
al., 2017).  
A primary aim of this study was to identify the effect of consuming different 
types of sugar found in commercially available SSBs on FMD and 
microvascular function and compare this to a control trial. This study also aimed 
to determine the effect of sucrose on macrovascular function. The effects of 
consumption of these sugars on metabolic function will also be assessed. The 
secondary aim of this study was to identify whether consumption of these 
sugars affected these outcomes in the postprandial stage following the 
consumption of a high-fat, high-sugar test meal. It is hypothesised that 
consumption of these sugars will impair macro- and micro- vascular function 
post-drink consumption and will increase plasma concentrations of [glucose], 
[lactate], [TAG] and [uric acid]. It is also hypothesised that consumption of these 
sugars will impair macro- and micro- vascular function in the postprandial phase 





Twenty two healthy adolescents (Table 5.3) volunteered to participate in this 
study.  
5.2.2 Preliminary visit: participant characteristics 
For participant characteristics data see Table 5.3. 
5.2.2.1 Anthropometrical measurements 
For methodology regarding body fat percentage, body mass index, maturation 
and pubertal status see 3.4.1. 
5.2.2.4 Assessment of cardiorespiratory fitness  
For assessment of cardiorespiratory fitness see 3.4.2. 
5.2.3 Visit 2, 3, 4 & 5: Experimental trial 
For experimental trial protocol see 3.5. 
5.2.3.1 Assessment of vascular function 
For FMD and microvascular assessment methodology see 3.5.2 and 3.5.3. 
FMD was assessed for the same 10 participants in Chapter 4 and assessed 
influence of CON and SUC only due to time constraints. FMD was not 
normalised for SRAUC as they were not related (R=0.12, P=0.48). 
5.2.3.2 Blood sampling and analyses 
For blood sampling and analyses protocol see section 3.6. 
5.2.4 Statistical analyses 
A repeated measures analysis of variance (ANOVA) was used to determine the 
main and interaction effects of time and trial for all outcomes. 
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A one-way ANOVA was used to assess the differences between trials for 
plasma [glucose], [lactate] and [uric acid] for combined post drink + meal 
incremental (iAUC) (iAUC-[Glucose], iAUC-[Lactate], iAUC-[Uric Acid] & iAUC-
[TAG]) and total (tAUC) (tAUC-[Glucose], tAUC-[Lactate], tAUC-[Uric Acid] & 
tAUC-[TAG]) area under the curve.  
Mauchly’s test of sphericity was used to assess homogeneity of variance and 
the degrees of freedom were adjusted using the Greenhouse-Geisser correction 
when necessary. Statistical significance was inferred at P<0.05.  
95% confidence intervals (CI) for the mean difference and effect sizes (ES) 
were also presented. Effect sizes were determined as the difference in means 
divided by the pooled standard deviation (i.e. Cohen’s d) and were included in 
order to determine the meaningfulness of the mean change in a variable using 
these thresholds: small (0.2), moderate (0.5) and large (0.8) (Cohen, 1988).  
Effect sizes for the ANOVA were presented as partial eta squared (ηp2), and 
interpreted as small (<0.06), moderate (0.06 to 0.14) and large (>0.14). Effect 
sizes were used to provide information about the magnitude of an effect in the 
absence of any clinically relevant thresholds for endothelial function in 
adolescents being available. There was no interaction or main effect of sex on 
any of the outcomes and data was subsequently always pooled for sex (male, 







Table 5.3. Participant characteristics.  
Age, y 14.3 + 0.4 
Body mass, kg 55.09 + 10.96 
Stature, m 1.64 + 0.08 
Body fat, % 22.0 + 9.0 
BMI (kg/m2) 20.36 + 3.00 
Overweight (n) 2 
Obese (n) 0 
VO2peak, L/min-1 2.13 + 0.60 
VO2peak, mL/kg-1/min-1 40.13+9.57 
Low fit (n) 7 
GET, L/min-1 1.20 + 0.37 
Pubertal stage 2 (n=3), 3 (n=2), 4 (n=15), 5 (n=2) 
BMI, body mass index. VO2peak, maximal oxygen uptake. GET, gas exchange 











Baseline diameter of the brachial artery. 
There was a time by trial interaction effect (P=0.02) for baseline diameter of the 
brachial artery. There were no significant differences between any of the trials 
at baseline (P>0.08) and 1 h post (P>0.18) for baseline diameter of the brachial 
artery. Baseline diameter of the brachial artery 3 h post was significantly higher 
in CON when compared to GLU and FRU (P<0.05, ES<0.50). There were no 
significant differences between any of the other trials at 3 h post. 
Peak diameter of the brachial artery. 
There was no effect of trial (P=0.90, ηp2=0.02) or a time by trial interaction effect 
(P=0.16, ηp2=0.15) for peak diameter of the brachial artery. There was an effect 
of time (P=0.02) for peak diameter of the brachial artery. Peak diameter of the 
brachial artery was significantly greater 3 h post when compared to baseline 
and 1 h post (P=0.02, ES<0.22). 
Percentage change in diameter of brachial artery from baseline (FMD). 
There was no effect of trial (P=0.07, ηp2=0.33) but there was an effect of time 
(P=0.03) for percentage change in FMD. FMD was significantly lower 3 h post 
when compared to 1 h post (P=0.03, 95% CI=0.2 to 3.3, ES=0.25) (Figure 
5.3.1). There were no significant differences for FMD between baseline and 1 h 
post and between baseline and 3 h post. The time by trial interaction effect 
approached, but did not achieve, statistical significance (P=0.06), however post 
hoc tests were performed due to the large effect size of this interaction 
(ηp2=0.27). 
There was no difference between SUC and CON for FMD at baseline (P=0.44, 
95% CI=-0.3 to 0.7, ES=0.08). There was a non-significant difference between 
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SUC and CON 1 h post but there was a medium effect between the trials 
(P=0.06, 95% CI=-0.7 to 3.5, ES=0.77). There was a non-significant difference 
between SUC and CON 3 h post but there was a medium effect between the 
trials (P=0.09, 95% CI=-0.3 to 3.3, ES=0.65).  
Shear rate. 
There was a time by trial interaction effect for shear rate (P=0.01). There were 
no significant differences between SUC and CON for shear rate at baseline and 
1 h post (P>0.47, ES<0.32). Shear rate was significantly higher in CON when 







































Figure 5.3.1. Percentage change in flow-mediated dilation (FMD%) (A) and 
SRAUC (B) data at baseline, 1 h post drink (1 hour post drink consumption) and 3 
h post meal (3 hour post meal consumption). Dashed line represents 
consumption of drink and meal, respectively. Data are displayed as mean + SD. 
* indicates interaction effect.  
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5.3.2 Microvascular function. 
Peak reactive hyperaemia (PRH).  Microvascular outcomes are presented in 
Figure 5.3.2. There was a time by trial interaction effect (P=0.01) for PRH. 
There were no significant differences between any of the trials for PRH% at 
baseline (P>0.40). 
PRH 1 hour post drink consumption (1 h post) was significantly greater in FRU, 
GLU and SUC (P<0.04, ES>0.51) when compared to CON. PRH 1 h post was 
significantly greater in FRU compared to SUC (P=0.03, 95% CI=7.0 to 153.3, 
ES=0.54). There were no significant differences 1 h post for PRH between FRU 
and GLU and between GLU and SUC (P>0.10). 
PRH 3 hour post meal consumption (3 h post) was significantly greater in FRU 
compared to CON, GLU and SUC (P<0.03, ES>0.54). There no significant 
differences 3 h post for PRH between CON, GLU and SUC (P>0.20). 
PRH was never different from baseline throughout the CON trial (P>0.06). PRH 
for FRU 1 h post was significantly higher when compared to baseline and 3 h 
post (P<0.001, ES>0.97) and there was no significant difference between 
baseline and 3 h post (P>0.27). PRH for GLU was significantly higher 1 h post 
when compared to baseline and 3 h post (P<0.03, ES>0.70) and was 
significantly higher at baseline when compared to 3 h post (P=0.01, 95% 
CI=25.3 to 142.7, ES=0.85). PRH for SUC was significantly higher 1 h post 
when compared to baseline and 3 h post (P<0.01, ES>0.74). There was no 
significant difference between baseline and 3 h post for SUC (P>0.16). 
Total reactive hyperaemia (TRH). There was no interaction effect (P=0.57, 
ηp2=0.04), or main effect of trial (P=0.84, ηp2=0.01) for the TRH (Figure 5.3.2). 
There was a main effect of time (P<0.001). TRH was always greater after the 
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Figure 5.3.2. Percentage change in peak reactive hyperaemia (PRH%) (A) and total 
reactive hyperaemia (TRH) (B) data at baseline, 1 h post (1 hour post drink 
consumption) and 3 h post (3 hour post meal consumption). Dotted lines represents 
consumption of drink and meal, respectively. Data are displayed as mean + SD. * 
indicates interaction effect.  
P<0.05: a, CON v FRU. b, CON v GLU. c, CON v SUC. d, FRU v GLU. e, FRU v SUC. 
f, GLU v SUC.  
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5.3.3 Bloods analyses. 
Plasma [glucose]. 
There was an interaction effect (P<0.001) and a main effect of trial (P<0.001) 
and time (P<0.001) for [glucose]. Plasma [glucose] was significantly higher at 
baseline for CON when compared to FRU and SUC (P<0.02, ES>0.60) (Figure 
5.3.3).  
Plasma [glucose] 1 h post was significantly higher in GLU when compared to 
CON, FRU and SUC (P<0.001, ES>1.11). Plasma [glucose] 1 h post was 
significantly higher in SUC when compared to CON (P=0.03, 95% CI=0.1 to 1.0, 
ES=0.72). There were no significant differences for plasma [glucose] 1 h post 
between CON v FRU and FRU v SUC (P>0.09). 
There were no significant differences in plasma [glucose] 3 h post between any 
of the trials (P>0.15).   
Post drink + meal iAUC-[Glucose] was significantly greater for GLU when 
compared to CON (P<0.005, 95% CI=50.1 to 258.8, ES=1.12) and FRU 
(P=0.05, 95% CI=0.6 to 209.4, ES=0.61). Post drink + meal iAUC-[Glucose] 
was significantly greater in SUC when compared to CON (P=0.02, 95% CI=16.6 
to 225.3, ES=0.69). Post drink + meal tAUC-[Glucose] was significantly greater 
for GLU when compared to CON, FRU and SUC (P<0.05, ES>0.92). For post 
drink + meal iAUC-[Glucose] and tAUC-[Glucose] data see Table 5.3.3. 
Plasma [lactate]. There was an interaction effect (P<0.001) and a main effect 
of trial (P<0.001) and time (P<0.001). There were no significant differences 
between trials at baseline (Figure 5.3.3).  
Plasma [lactate] 1 h post was significantly higher in FRU when compared to 
CON (P<0.001, 95% CI=1.5 to 1.9, ES=4.27) and GLU (P<0.001, 95% CI=0.8 
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to 1.3, ES=2.29). Plasma [lactate] was significantly higher 1 h post in SUC 
when compared to CON and GLU (P<0.001, ES>1.21). Plasma [lactate] was 
significantly higher in GLU when compared to CON (P<0.001, 95% CI=0.5 to 
0.9, ES=1.52). There was no significant difference between FRU and SUC 
(P>0.05). 
Plasma [lactate] 3 h post was significantly higher in SUC when compared to 
GLU (P=0.01, 95% CI=0.0 to 0.3, ES=0.19). There were no significant 
differences for plasma [lactate] between any of the other trials 3 h post (P>0.06, 
ES<0.45). 
Post drink + meal iAUC-[Lactate] was significantly greater in FRU when 
compared to CON (P<0.001, 95% CI=103.3 to 200.4, ES=2.08), GLU (P<0.001, 
95% CI=82.6 to 179.6, ES=1.66) and SUC (P=0.02, 95% CI=8.9 to 105.9, 
ES=0.60). Post drink + meal iAUC-[Lactate] was greater in SUC when 
compared to CON and GLU (P<0.005, 95% ES>0.84). Post drink + meal tAUC-
Lactate was significantly higher in FRU when compared to CON, GLU and SUC 
(P<0.05, ES>0.79). Post drink + meal tAUC-Lactate was significantly higher for 
SUC when compared to CON and GLU (P<0.01, ES>1.10). For post drink + 
meal iAUC-[Lactate] and tAUC-[Lactate] data see Table 5.3.3. 
[Uric Acid]. There was an interaction effect (P=0.03) and a main effect of trial 
(P=0.01) and time (P=0.01) for [uric acid]. There were no significant differences 
between trials for baseline [uric acid].  
[Uric acid] 1 h post was significantly higher in FRU when compared to CON, 
GLU and SUC (P<0.03, ES>0.56) (Figure 5.3.3). There were no significant 




There were no significant differences between trials for [uric acid] 3 h post 
(P>0.07, ES<0.40). 
There were no significant differences for post drink + meal iAUC-[Uric Acid] 
(P<0.40) and tAUC-[Uric Acid] (P>0.10). For post drink + meal iAUC-[Uric Acid] 
and tAUC-[Uric Acid] data see Table 5.3.3. 
TAG. There was no interaction effect (P=0.16, ηp2=0.07) or main effect of trial 
(P=0.12, ηp2=0.09) for plasma [TAG] concentration. There was a main effect of 
time (P<0.001). Plasma [TAG] was always significantly higher 3 h post when 
compared to baseline and 2 hours post drink consumption (P<0.001, ES>1.55) 
(Figure 5.3.3). 
There were no significant differences for post drink + meal iAUC-[TAG] (P<0.07) 
and tAUC-[TAG] (P<0.10). For post drink + meal iAUC-[TAG] and tAUC-[TAG] 
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Figure 5.3.3. Data for plasma [glucose] (A), [lactate] (B), [uric acid] (C) and 
[triacylglycerol] (D; [TAG]) for each trial. Dotted lines represents consumption of 
drink and meal, respectively. Data are displayed as mean + SD. * indicates 
interaction effect. 
P<0.05: a, CON v FRU. b, CON v GLU. c, CON v SUC. d, FRU v GLU. e, FRU 
v SUC. f, GLU v SUC. 
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Table 5.3.3. Combined post-drink and meal incremental area under the curve 
(iAUC) and total area under the curve (tAUC) data for plasma glucose, lactate 
and uric acid for each trial.  




































































































































All data are expressed as mean + standard deviation. 
P<0.05: a, CON v FRU. b, CON v GLU. c, CON v SUC. d, FRU v GLU. e, FRU 





This study aimed to distinguish the effects of fructose, sucrose and glucose, 
sugars found in commercially available SSBs, on FMD, microvascular function 
and metabolic outcomes in healthy adolescents.  
The main finding of this study was that there was no significant influence of 60 g 
of sucrose consumption on FMD when compared to a control trial. However, 
with a P value of 0.06 and a ηp2 of 0.27, a large effect size, it is suggested that 
the lack of significance is as a result of a small sample size for FMD (n=10). 
Therefore, the current study concludes that there was a large but non-significant 
difference between SUC and CON for FMD following drink consumption. These 
data indicate that SSB consumption may alter vascular reactivity in adolescents, 
and this effect can still be observed following a meal.  
Our findings for FMD are consistent with Dengel et al. (2007) which evidenced a 
~2% increase in FMD following an OGTT in adolescents and a study which 
demonstrated improved vascular function following glucose and dextrose 
infusion which induced hyperglycaemia in adolescents (Dye et al., 2012).  Our 
data however contradict those from Loader et al. (2017) which reported an 
attenuation in FMD in adults following SSB consumption (Loader et al., 2017). 
As this is the first study which has assessed the effect of sucrose on FMD in 
adolescents, the mechanisms behind these findings are currently unknown. A 
more thorough assessment of [insulin] and redox state would be advantageous 
to provide an insight into these findings as insulin is a known vasoactive 
hormone and adolescence is associated with a period of insulin resistance 
(Bloch et al., 1987; Baron, 2002) and oxidative stress has been linked to 
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endothelial dysfunction by inactivating NO (Higashi et al., 2009). However, 
assessing these outcomes was not the purpose of the investigation. A novelty 
of this study compared to previous paediatric research is the use of sucrose 
rather than glucose. In their study Dengel et al. (2007) used a glucose load 
which was aligned with the body weight of the participant (1.75 g/kg of 
bodyweight; maximum of 75 g) and Dye et al. (2012) infused glucose and 
dextrose into an antecubital vein to raise plasma [glucose] to induce a 
hyperglycaemic state (200 mg/dL of plasma [glucose] for 60 minutes). The 
current study used 60 g of sucrose which is better representative of the sugar 
load in commercially available SSBs (Loader et al., 2017) and contains fructose 
which is metabolised differently to glucose (Lustig, 2012). In their study, Loader 
et al. (2017) used a commercially available SSB which constituted of sucrose 
which aligned with the current study. The differences in our data and Loader et 
al. (2017) is most likely attributed to the adolescent population used in the 
current study which is supported by paediatric data which has evidenced 
improved vascular function in adolescents from either an OGTT (Dengel et al., 
2007) or glucose and dextrose infusion (Dye et al., 2012). These findings 
suggest that the vasculature respond differently to sugars in adolescents when 
compared to adults and future research should explore the differences between 
these populations to provide further insight into the effects of SSB consumption. 
Another important finding of this study was that microvascular function following 
consumption of 60 g of fructose, sucrose or glucose, measured using laser 
Doppler flowmetry and defined by PRH, increased 1 hour following drink 
consumption in all trials and the increase was greatest in the FRU trial. 
Consumption of the test meal attenuated PRH to baseline level in the FRU and 
SUC trial and below baseline in the GLU trial. There was no observed 
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differences between the trials for TRH. Data indicated a wide CI for the effects 
of FRU when compared to CON on PRH. This could potentially be due to the 
small sample size used in this study but can also be attributed to body 
composition. In the current study, there was a standard deviation of 11 kg for 
participant mass and previous research has investigated the influence of body 
composition on reactive hyperaemia in healthy men and women (Wascher et 
al., 1998). In this study it was determined that an increase in forearm muscle 
mass was associated with an increase in reactive hyperaemia. These findings 
demonstrate that the wide variability for the PRH outcome between FRU and 
SUC could be as a result of the variability in mass between our participants. 
The variation in body composition could be reflective of the different biological 
ages/stages of maturation and sex differences within our sample which is 
typical when working with adolescents. 
The findings for PRH are consistent with Grasser et al. (2014) which 
demonstrated that SSB-induced hyperglycaemia also increased microvascular 
function in adults. The SSB used in that study contained 39.1 g of sucrose and 
glucose and 114 mg of caffeine. Their study failed to distinguish whether the 
increase in microvascular function was as a result of the sucrose or the caffeine 
which has been shown to improve microvascular function (Tesselaar et al., 
2017; Noguchi et al., 2015). The findings from the current study support the 
notion that sucrose increases microvascular function in adolescents. In the 
current study the increase in PRH was greatest in FRU but did increase in SUC 
and GLU suggesting that fructose consumption increases microvascular 
function beyond other sugars 1 hour following consumption of the drink. The 
influence of consumption of fructose, sucrose and glucose on microvascular 
function in the current study was only observed in PRH and not TRH which is 
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known not to be NO-mediated (Wong et al., 2003). The current mechanisms for 
PRH are currently unknown which makes it difficult to determine an explanation 
for our findings but based on current knowledge it is a possibility that 
consumption of these sugars increases the availability/production of NO in the 
microvasculature in adolescents which causes an increase in PRH. This is 
contradicted in the literature where it has been reported that NO synthase 
inhibitors (Wong et al., 2003; Engelke et al., 1996) do not influence the post-
occlusive microvascular response. However, Engelke et al. (1996) also reported 
a 33% fall in TRH when prostaglandins are inhibited with ibuprofen prior to the 
administration of the NO synthase inhibitor. This suggests that prostaglandin 
inhibition might determine a role for NO in PRH. Combined sensory nerve and 
prostaglandin inhibition has also been determined to cause a 72% reduction in 
the post-occlusive response (Larkin & Williams, 1993). Therefore, it is likely that 
the mechanisms behind the functioning of the microvasculature are controlled 
by a series of endothelium dependent and independent mechanisms. Further 
research is required to determine these mechanisms before conclusions of why 
consumption of dietary sugars increase microvascular function can be drawn. 
The reduction in microvascular function in Loader et al. (2017) may be 
explained by the adult population used in their study. Dengel et al. (2007) 
concluded that age, which is a surrogate of vessel health, might have an 
interaction effect on the hyperglycaemic vascular response. The current study 
recruited adolescents and adolescence is consistent with a period of insulin 
resistance and as insulin is a vasoactive hormone, insulin-resistance causes 
impairments to insulin-mediated and endothelium-dependent vasodilation 
(Bloch et al., 1987; Baron, 2002). Our findings could be attributed to this 
however, a limitation of this work is that [insulin] was not assessed to determine 
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whether our findings could be attributed to this outcome. Further research is 
required to assess [insulin] following consumption of fructose, sucrose and 
glucose in adolescents to determine whether microvascular function is 
associated to [insulin]. 
The majority of the studies reported in Loader et al. (2015) were carried out on 
an adult population meaning that findings from these studies are not reflective 
of the age-related difference in microvascular function of adolescents (Gates et 
al., 2009). Adult ageing is associated with a reduction in microvascular 
endothelial function (Gates et al., 2009). Therefore, more paediatric research is 
required to be done exploring the effects of SSB consumption on vascular and 
metabolic outcomes in youth. The findings from this study suggest that 
consumption of sucrose, fructose and glucose increases microvascular function 
in adolescents and the increase in greatest following fructose consumption. 
These findings are important as they suggest there is a difference between the 
vascular response to SSB consumption between adults and adolescents and 
further research is needed to be done to explore whether these observations 
are consistent with findings from future studies. 
An aim of this study was to assess the independent influence of fructose, 
sucrose and glucose consumption on metabolic responses. The findings 
determined that consumption of these sugars produced significantly different 
responses for metabolic outcomes and it is important to consider their effects on 
the vasculature before and after consumption of the drink as well as in the 
postprandial phase. Previous research has demonstrated that the postprandial 
change in [TAG] and [glucose] are unrelated to FMD demonstrating the need to 
assess metabolic outcomes in addition to vascular outcomes (Bond et al., 
2015a, c).  
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Plasma [glucose] did not elevate in FRU and responded similarly to CON 
following drink and meal consumption. However, plasma [glucose] was elevated 
following drink consumption in GLU and to a lesser extent in SUC. The 
elevation in plasma [glucose] in SUC is cause for concern due to it being the 
main sugar constituent in commercially available SSBs (Loader et al., 2017) 
and the relationship between hyperglycaemia and CVD. According to the World 
Health Organisation, 2.2 million deaths in 2012 were linked to hyperglycaemia 
(WHO, 2016b). In their study, Levitanen et al. (2004) demonstrated that 
hyperglycaemia under the diabetic threshold is associated with an increased 
risk of fatal and nonfatal CVD and a similar association is apparent between 
CVD related events and fasting or 2 h postprandial plasma [glucose]. 
Additionally, treatment with acarbose, a α-glucosidase inhibitor which reduces 
postprandial plasma [glucose], has been shown to reduce the risk of CVD 
events (Hanefield et al., 2004) implicating postprandial plasma [glucose] in the 
development of CVD. It is suggested that the association between plasma 
[glucose] and CVD is as a result of oxidative stress (Davidson & Parkin, 2009; 
Fiorentino et al., 2013) which is known to be implicated with CVD (Cervantes 
Gracia et al., 2017) and has been suggested to be the underlying cause of 
macro- and micro- vascular complications from type 2 diabetes (Khatri et al., 
2004; von Harsdorf et al., 1999; Brownlee, 2001). Adolescents therefore are at 
risk of obtaining CVD from chronic SSB consumption and future interventions 
are required to reduce SSB intake in this population.   
Plasma [lactate] increased in FRU, GLU and SUC and increased similarly in 
FRU and SUC following drink consumption and remained elevated in SUC 
following meal consumption. This is consistent with previous research which 
demonstrated that consumption of fructose-sweetened beverages increased 
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plasma [lactate] concentrations significantly more than consumption of glucose-
sweetened beverages (Teff et al., 2009). The findings from the current study 
and Teff et al. (2009) suggest that fructose increases [lactate] significantly more 
than consumption glucose. The increase in [lactate] as a result of fructose 
consumption is associated with an increase in lipogenesis (Carmona & 
Freedland, 1989; Walli, 1978) which previous research has demonstrated is a 
response to fructose (not glucose) consumption in humans (Samuel, 2011). 
However, the findings in the current study are not consistent with this with 
fructose not inducing an increase in plasma [TAG]. A limitation of this study is 
that VLDL concentrations were not assessed which would have provided an 
insight into the metabolic fate of fructose and de novo synthesis of [TAG]. 
FRU was the only trial to induce an increase in [uric acid] following drink 
consumption. Early research has demonstrated similar findings where the rapid 
intravenous infusion of fructose resulted in an increase in [uric acid] (Fox & 
Kelley, 1972). Another study demonstrated that both artificial and natural 
fructose-rich rich beverages were associated with an increase in [uric acid] 
whereas diet soft drinks, which did not include fructose, did not increase [uric 
acid] (Choi et al., 2008). These findings support the notion that fructose induces 
an increase in [uric acid] and it has been proposed that this is as a result of 
fructose causing an increase in ATP degradation to AMP which is a known uric 
acid precursor (Choi et al., 2005; Gibson et al., 1983; Fox & Kelley, 1972). Uric 
acid has been demonstrated to be an independent predictor of CVD events in 
healthy men and women (Kivity et al., 2013) and an independent risk factor for 
myocardial infarction (Krishnan et al., 2006). Childhood [uric acid] has also been 
found to be predictive of diastolic and systolic blood pressure in adulthood 
(Alper Jr et al., 2005). Thus, an increase in [uric acid] as a result of fructose 
90 
 
consumption, a sugar found in commercially available SSBs, is implicated in 
CVD and childhood levels of [uric acid] are related to CVD risk factors in later 
life.  
There were no significant differences between any of the trials for plasma [TAG] 
although [TAG] did increase following consumption of the meal but did not 
change following consumption of any of the drinks. It was expected that fructose 
consumption would cause an increase in plasma [TAG] in line with the increase 
in [lactate] due to the association between lipogenesis and plasma [lactate]. 
However, [TAG] did not increase as a result of fructose consumption and 
assessment of VLDL concentrations would provide insight into these findings. 
This is consistent with previous research which has demonstrated that 
consumption of <100 g/d of fructose had no effect on [TAG] when participants 
were fasted beforehand (Livesey & Taylor, 2008) and no change in AUC for 
[TAG] following consumption of glucose and sucrose (Jameel et al., 2014). Our 
findings that [TAG] did not increase following consumption of fructose but 
[lactate] did are consistent with findings from previous research which 
demonstrated no increase in [glycerol] but an increase in [lactate] following 
consumption of a fructose meal (Brundin & Wahren, 1993). 
Conclusions 
This study is the first to explore the effects of sucrose, fructose and glucose on 
vascular and metabolic outcomes in adolescents. As these are sugars found in 
commercially available SSBs and it is in this population that SSBs are 
consumed the most in the UK this work provides an insight into the vascular 
and metabolic health of adolescents in the UK. The techniques used to assess 
vascular function are reliable and widely used in the literature and by following 
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current guidelines (Thijssen et al., 2019) this study has provided an insight, 
which has minimised for known sources of error, into the effects of dietary 
sugars on vascular function in adolescents. By exploring the effects of these 
sugars on these outcomes following consumption of a high-fat, high-sugar test 
meal these findings also provide an insight into the postprandial effect of these 
sugars.  
The current study has shown that consumption of sucrose causes a non-
significant increase in macrovascular function of the brachial artery in healthy 
adolescents and this increase is still apparent when compared to control 
following consumption of a high-fat, high-sugar test meal which attenuated 
FMD. Alongside the increase in FMD, microvascular function of the cutaneous 
circulation of the forearm also increased following consumption of fructose, 
sucrose and glucose in adolescents. The mechanisms behind the increase in 
vascular function are unknown and further research is required to assess the 
effect of consumption of these sugars on insulin and redox state to determine 
whether the increase in vascular function observed in this study can be 
explained by these outcomes.  
Implications 
For future trials with a larger sample size, the amount of time available needs to 
be considered with regards to how many participants can be assessed within a 
day and over the course of the trial if all FMD analysis is to be carried out by a 
single assessor. Participants may need to be recruited from more than one 
school (or from multiple sources) for larger trials as all that volunteered for the 
current study were recruited with the exception of those that dropped out during 
the study or were excluded for behavioural concerns at school. The current 
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study specifically recruited healthy 14-15 year olds and it was observed that 
those which volunteered had an interest for the area of study. This could be 
considered a source of bias, but it is unavoidable that pupils which find the area 
interesting will be more likely to volunteer for the study. Future studies could 
overcome the bias of age by investigating the influence of these sugars on 
vascular and metabolic outcomes in other age groups to determine whether 
they occur differently to the age group used in this study. Additionally, future 
studies could investigate the influence that consumption of these sugars have in 
unhealthy populations such as in those with diabetes and compare findings to a 
healthy population. 
As the current study demonstrated that single consumption of sugars found in 
SSBs improve acute microvascular function, future research may wish to 
explore the influence of chronic/daily consumption of these sugars on the 
vasculature through an observational study of those which regularly consume 
SSBs. This will provide a better reflection of habitual consumption of these 
sugars. Furthermore, future research may wish to explore the influence of FRU 
and GLU on FMD as the current study only explored the effects of SUC on FMD 
when compared to CON. This will provide a more detailed insight into the 
influence of sugars found in SSBs on the macro- vasculature.  
Another limitation of this study was that the taste aspect of the drinks was not 
controlled for with fructose having a sweeter taste. Future studies could control 
for this by using a non-sugar-based sweetener in the glucose, sucrose and 
control drinks to ensure that all drinks taste the same.  
The vascular measures in this study were also not standardised to the peak 
appearance time of each type of sugar consumed as this was not possible for 
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the current thesis. Chong et al. (2007) identified that plasma glucose 
concentrations peak between 30 and 60 min following independent feeding of 
glucose and fructose. This has been supported by Abraha et al. (1998) which 
found that plasma glucose peaked 30 min following fructose feeding and 
remained constant up to 60 min in non-diabetic subjects. It is understood that 
the time course of blood fructose and glucose will differ between trials but the 
standardised 1 hour post drink time point for vascular analysis was picked as it 
would not be possible to align plasma [glucose] measurement with peak 
[glucose] or [fructose] (which was not measured in this study) within an 
individual. Future research may wish to use separate groups for each trial to 
ensure that assessment of vascular function can be standardised to align with 
the peak in [glucose] which will provide a more accurate insight into the 
metabolic response to these sugars. Additionally, another limitation of this study 
was that plasma [fructose] was not assessed. As fructose consumption has 
been associated with an increase in cardiovascular risk it may be important to 
assess [fructose] following consumption of the sugary drinks. Future research 
could assess this to determine whether consumption of these sugars produce 
different responses between [glucose] and [fructose].  
Although the current study demonstrated that consumption of sugars found in 
SSBs improves microvascular function in the acute phase, it is important that 
this is not used to promote consumption of SSBs. It is important to remember 
that the findings from the current study are based on single consumption of 
sugars found in SSBs and not consumption of these sugars over time. 
Research has shown that increased consumption of SSBs can result in 
increased risk of coronary heart disease, diabetes, greater waist circumference, 
systolic blood pressure and metabolic syndrome (Huang et al., 2014; Basu et 
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al., 2013; Chan et al., 2014). Thus, before changes in advertisement and policy 
can be made further research is required to explore the effects of chronic SSB 
consumption on the vasculature and metabolic outcomes over time. Parents 
and schools should continue to take similar precautions to what they do now as 



















Chapter 6: Conclusions 
 
The aim of the current thesis was to expand our understanding of the vascular 
and metabolic responses to consumption of sugars found in commercially 
available SSBs. Two studies were completed to achieve this which addressed 
the following: 
1. Are assessments of flow-mediated dilation and laser Doppler flowmetry 
reliable for the assessment of macro- and microvascular function? - 
Reliability chapter 
2. What are the acute and postprandial macrovascular, microvascular and 
metabolic responses to consumption of fructose, sucrose and glucose? - 
Experimental chapter 
Experimental considerations and future directions 
The current thesis is an addition to the literature regarding the effects of SSBs 
on vascular and metabolic function in adolescents. The work in thesis was 
performed in a counterbalanced order in a controlled study with the drinks being 
delivered in a double blind manner. Previous research has focused on the 
effects of glucose which is not representative of commercially available SSBs. 
The work in this thesis is the first to assess the individual effects of sucrose, 
fructose and glucose, the sugars found in commercial SSBs, on vascular and 
metabolic outcomes. This research adds to the literature as sucrose is the main 
sugar constituent of commercially available SSBs and it is made up of equal 
parts of glucose and fructose and these sugars are metabolised differently. The 
metabolism of fructose has been implicated with CVD risk factors thus making it 
important for the effects of these sugars to be assessed. Furthermore, 
adolescents are the highest consumers of SSBs in the UK making them 
vulnerable to the reported effects of SSB on cardiovascular health. Assessing 
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these outcomes following a high-fat, high-sugar test meal also provides insight 
into the postprandial effects of consumption of these sugars. The work here 
indicates that consumption of these sugars increase vascular function in 
adolescents which suggest that they may be good for vascular function 
however, the mechanisms behind this are uncertain. Further work is required to 
determine whether there are age-related differences in the vascular response to 
SSB consumption. If this is the case then research also needs to assess 
whether these changes are as a result of the age-related differences in insulin 
resistance and/or whether redox state also plays a role. 
Conclusion 
The research regarding the effects of SSBs on vascular and metabolic function 
are ongoing however, the effects of sucrose, the sugar known to make up 
SSBs, on these outcomes is more recent. The current thesis aimed to 
determine the effects of glucose, sucrose and fructose on these outcomes in 
adolescents in the acute and postprandial phase. It can be determined that 
consumption of these sugars increase vascular function in the acute phase 
(post-drink) and although consumption of a high-fat meal does attenuate 
vascular function, when compared to a control trial the elevation was still 
apparent in the sucrose trial for FMD and the fructose trial for microvascular 
function. The mechanisms behind these outcomes are unknown however, it is 
suggested that investigations into insulin resistance and redox state may 
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Chapter 9: Appendix 








Web:  www.ex .ac .uk /s s hs  
Participant Information Sheet 
Study title To examine whether the consumption of different types of sugar 
(fructose, glucose and sucrose) impairs blood vessel health in adolescents when 
compared to the consumption of water. 
Invitation and brief summary  
We would like to invite your child to take part in a research study into the effects of sugar 
sweetened drink consumption on blood vessel health in adolescents. Taking part in the 
study is entirely up to you and your child so before you decide, it is important for you to 
understand why the research is being done and what it will involve. Please take the time 
to read the following information and to discuss it with other people to decide whether 
you wish for your child to take part or not. Thank you for taking the time to read this 
information. Please be aware that participation in this study means that your child will be 
required to spend approximately five school days outside of school/the classroom. 
What’s involved?   
High sugar consumption in youth is linked with poor blood vessel and metabolic health 
and obesity. Worryingly, teenagers in the UK are known to consume eight times the 
recommended maximum amount of added sugar from sugary drinks alone. However, the 
effect of sugary drinks on blood vessel function in adolescents is poorly understood. This 
study will investigate the effect of different sugar types found in sugary drinks on blood 
vessel health. We will do this by using a range of non-invasive techniques (including the 
use of ultrasound) and also by taking a series of fingertip capillary blood samples (<1 mL 
each) to measure the response to different sugary drinks. We will also see if sugary drink 
consumption influences the blood vessel response to a subsequent meal (Pizza, ice 
cream and a chocolate pudding).  
What would taking part involve?  
We have invited your child to take part because we are looking for healthy participants 
between the ages of 12-15 years old. We will be inviting 30-35 male and female 
participants to take part.  
If you would like your child to take part they will be asked to attend a laboratory at the 
University of Exeter’s St. Luke’s campus on five separate occasions. You will be asked 
to visit our laboratory in a group of two or three for all visit.  
 
Preliminary testing visit (visit 1) 










Sport and Health Sciences 
College of Life and Environmental Sciences 
 








This will take four hours. Having completed and handed in participant assent, parental 
consent, health screening and contact details forms, we will collect your child from 
school at 7.30 am and drive them to the University for their familiarisation visit. This 
visit will initially provide your child with an opportunity to discuss with the investigators 
any questions they may have regarding any aspect of the study’s objectives, 
procedures or results. 
If your child wishes to continue to take part, the rest of this visit will involve some 
preliminary measurements including, height, sitting height, body weight and body fat 
percentage (using a machine in which you sit inside a chamber). We will also take a 
resting measure of your child’s blood pressure. We will then familiarise your child with 
all testing procedures and what to expect on future visits, so that they can make sure 
that they would like to take part. This includes non-invasive measures of blood vessel 
function at three different sites; the arm, forearm and head. We will also demonstrate 
how we take small capillary blood samples from the fingertip as this will be done on 
future visits.  
After we have shown all the techniques, and providing that your child is still happy to 
take part, we will measure blood vessel function in the arm. This involves sticking a 
small laser probe to your child’s forearm, and scanning the large blood vessel in the 
bicep using ultrasound. We will then pump up a blood pressure cuff around the forearm 
of the same arm for 5 minutes. During this time, your child may experience pins and 
needles in their hand, but this is normal and short lived. We often use this technique for 
our research with teenagers, and it is well tolerated. Following this we will also 
measure blood vessel function within the head by placing a small ultrasound probe at 
the temple, and asking your child to hold their breath for 30 seconds. Blood vessel 
function at the head will also be measured during a 5 minute period where we ask your 
child to sit and stand repeatedly. 
Your child will then be asked to perform a cycling test to maximal effort cycle test. This 
test will feel like cycling up a hill as it gets steeper and steeper until your child can no 
longer carry on. It will only feel very hard at the end. During this cycle test your child will 
be wearing a heart rate monitor and a face mask in order to determine their aerobic 
fitness. We will also monitor blood flow to the head using the ultrasound probe at the 
temple as used above, monitoring your child throughout this time. After the exercise 
test, measures of blood vessel health in the arm and head will be repeated as above 
using non-invasive ultrasound. Measures of blood pressure will also be routinely 
assessed following the exercise bout.  
Before we drive your child back to school (at ~ 12.30 pm) they will be given an 
instruction pack for the remainder of the study. Your child will be required to;  
1. Wear an accelerometer (a small activity monitor which looks like a wrist watch) for 7 
days prior to the first visit and then 2 days prior to each subsequent visit. They will 
hand this in to our research team during the subsequent visits.  
2. Record their food intake on the two days prior to each subsequent visit.  
3. Avoid any structured moderate or vigorous intensity physical activity (other than day 
to day tasks) for 48 hrs prior to their next visit. 
4. Refrain from eating or drinking anything apart from water after 8 pm the night before 
all laboratory visits. 
5. Take home a set of scientific drawings showing five stages of pubic hair 
development and circle the picture that best describes them. They will seal this in an 
envelope and return it to us on their next visit.  
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Trials 1-4 (visits 2, 3, 4, 5) 
Each trial day will last from 8.00 am to 2.40 pm. As for visit 1, we will collect your child 
form school at 7.30 am having not had any breakfast. The following procedures will be 
included in these visits:  
• 8 am - We will assess the health of your child’s blood vessels by scanning the 
artery in the arm and side of the head as described in visit 1. 
• 9 am – Your child will then be given one of three sugary drinks or water (to act 
as a comparison), receiving a different one on each visit.  
• A small sample of blood (less than 1mL, or about the size of a pin head) will be 
taken from your child’s fingertip every 30 mins for the first 2 hours and then 
every hour following for the next 3 hours. 
• Hunger levels will be assessed requiring your child to report their hunger on a 
visual scale,  60 and 120 minutes after sugary drink consumption, and 180 
minutes after test meal consumption. 
• 10 am - Blood vessel health will then be reassessed after 35-75 minutes. As 
well as measures of blood pressure.  
• 11am – Your child will then be given a meal of a pizza, ice cream and a 
chocolate pudding. 
• During this time, we will discuss with your child aspects of sports science, 
medicine and nutrition. Your child will also be able to watch a film, play on the 
Playstation® or do some school work. 
• 2 pm - Three hours after the breakfast we will measure your child’s blood vessel 
health and blood pressure. After this measurement, we will drive you child back 
to school for 3.30 pm.  
What are the possible benefits of taking part?  
The main benefits of the proposed research are educational and there will be limited 
personal benefit to your child. However, the results will increase our understanding of 
the risks associated with sugar intake and the different types of sugars found in sugary 
drinks.  The study will hopefully be enjoyable and interesting for your child and allow 
them to learn about exercise physiology and nutrition in a fun and interactive way. By 
taking part your child will get to spend time in a University Laboratory, and we will give 
you access to full fitness and nutrition assessment from our report. This study will give 
your child first-hand experience about what it’s like to be involved in science at a higher 
level. 
What are the possible disadvantages and risks of taking part?  
Blood sampling can cause some temporary discomfort if participants are not 
comfortable with blood. However, this technique is used extensively in physiological 
testing. The investigators are trained and experienced in all aspects of these 
procedures to ensure that they are performed safely and with the minimum possible 
discomfort.  
Does my child have to take part? 
Please remember that participation in this study is entirely voluntary. It is up to you and 
your child to discuss and decide whether you would like them to take part or not. If you 
decide for them to take part they free to leave the study at any time without giving a 
reason as to why they wish to do so.  
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If you and your child do agree for them to participate in this study then please complete 
the following:  
• Sign the parent/guardian consent form 
• Sign the child assent form 
• Complete the contact details form 
• Complete the health questionnaire  
Please return these documents to your child’s school in the brown envelope provided, 
so we can collect them. A member of the research team will then be in contact to 
arrange your child’s involvement in the study. You will also be given a copy of the 
forms and this information sheet for your own records. 
Are my results confidential? 
If you consent to take part in this study you have a right to privacy. Your child’s name 
will be linked to an ID number on a password protected database and only these IDs 
will be used as labels during blood and data analysis.  
What will happen to the results of this study? 
The results will increase our understanding of the risks associated with different types 
of sugars found in sugary drinks. We will aim to publish the findings as a masters by 
research project, in research journals and to present them at conferences in the UK or 
abroad. Your data will always remain anonymous and your name will not appear on 
any results. However, we will explain all your results of the study to you at the end if 
you would like to know them. 
Who has reviewed this study? 
All research activity at the University of Exeter is examined and approved by an ethics 
committee to protect your interests. This study has been approved by the Ethics 
Committee of Sport and Health Sciences, College of Life and Environmental Sciences, 
University of Exeter. 
Who is funding/sponsoring this study? 
This study will be funded by the University of Exeter. 
Contacts for further information 
If you would like more information or if you have any further questions about the study 
please contact the investigators using the details below: 
 
 
Ms Jodie Koep   Dr Alan Barker  Dr Bert Bond  
Sport and Health 
Sciences 
Sport and Health 
Sciences 
Sport and Health 
Sciences  
Baring Court   Baring Court  Baring Court  
St. Lukes Campus St. Lukes Campus St Lukes Campus  
Exeter University Exeter University Exeter University  
EX12LU EX12LU EX12LU 
Tel: 07769226211 Tel: 01392 722766 
 










Appendix 3: Parental/Guardian Consent Form 
 
 
 Sport and Health Sciences 
College of Life and Environmental 
Sciences 
 
St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU 
Telephone: +44 (0)1392 26 
Email: sshs-school-office@ex.ac.uk  
Web:  w w w . e x . a . u k  
 
Study: To examine whether the consumption of different types of sugar 
(fructose, glucose and sucrose) impairs blood vessel health in adolescents 
when compared to the consumption of water. 
Researcher: Jodie Koep (MSc) 
Organisation: The University of Exeter 
Version: #2 15/01/18: reviewed by The University of Exeter ethics committee 
Participant Identification Number:    ID no.      
  
Informed consent form for parent/guardian  Please 
initial 
box 
I confirm that I have read and understand the information sheet 
version #2 15/01/2018 for the above study. I have had the 
opportunity to consider the information, ask questions and have 




I understand that my child’s participation is voluntary and that I 
am free to withdraw them at any time, without giving any reason. 
  
 
I understand that any information given by me may be used in 
future reports, articles or presentations by the research team. 
  
 
I understand that my child’s name will not appear in any reports, 
articles or presentations.  
  
 
I understand that my child will perform an incremental cycle tests 
to exhaustion on their first visit. 
 
I understand that my child will be required to drink three high 
sugar drinks or water on four separate occascions. 
 
  
Ultrasound will be used to determine changes in the width of the 
arm artery. A laser will also be placed onto the forearm to 
quantify skin blood flow. All of these techniques are routinely 







I can confirm the absence of any food allergies related to this 
study.  
 
I understand that ultrasound will be used to measure the speed of 
blood flow at the side of the head during a 30 second breath hold 




I understand that my child will be asked to record dietary 
information and wear an accelerometer to measure their physical 
activity. My child will consume the same meal no later than 8:00 
pm before each visit to the laboratory. 
 
I understand that my child will be required to assess their 
pubertal status according to five drawings of secondary sex 
characteristics. The purpose of this has been made clear to me. 
  
 
I understand that on each of the four test visits five capillary blood 
samples will then be taken from the fingertip (<1 mL each time) in 
order to measure fat, sugar, insulin in the blood. 
 
I understand that on each of the four test visits my child will have 
to consume a meal provided consisting of a pizza, ice cream and 






I understand that on each visit my child will 
have their blood pressure measured by placing 
a cuff around their bicep which will be inflated 
during measurement.  
 






Name of Parent/Guardian  Date  Signature 
     
     
Name of Researcher  Date  Signature 


















 Sport and Health Sciences 
College of Life and Environmental 
Sciences 
 
St Luke’s Campus, Heavitree Road, Exeter, EX1 
2LU 
Telephone: +44 (0)1392 26 
Email: sshs-school-office@ex.ac.uk  
Web:  www.ex .a .uk  
 
Study: To examine whether the consumption of different types of sugar 
(fructose, glucose and sucrose) impairs blood vessel health in 
adolescents when compared to the consumption of water. 
Researcher: Jodie Koep   
Organisation: The University of Exeter 
Version: #2 15/01/18 reviewed by The University of Exeter ethics 
committee 
Participant Identification Number:    ID no. 
            
Informed assent form for participants  Please 
initial 
box 
I confirm that I have read and understood the 
information sheet version #2 15/01/2018 for the above 
study. I have had the opportunity to consider the 





I understand that my participation is voluntary and that I 




I understand that any information given by me may be 




I understand that my name will not appear in any 
reports, articles or presentations.  
 
I understand that I will have to perform an incremental 




I will be required to drink three high sugar drinks or 
water on four separate visits. 
 
 
Ultrasound will be used to measure changes in the 
width of the artery in my arm, and a laser will be placed 
on my forearm to measure changes in skin blood flow. 
This will happen before and after a blood pressure cuff 
is inflated below my elbow for 5 minutes. During this 
time I may experience “pins and needles” in my hand.  
  
Ultrasound will be used to measure the speed of blood 
flow at the side of the head during a 30 second breath 
hold and when performing 5 minutes of repeatedly 
sitting and standing. 
  
I understand that  5 small (<1 mL) of blood will be taken 
from the fingertip to measure the amount of fat, sugar 
and insulin in my blood. 
 
On all test visits, I will have to consume a meal which 
will be provided, consisting of a pizza, ice cream and 
chocolate pudding. I will not have eaten beforehand. 
 
I will be required to assess my pubertal status 
according to five drawings of secondary sex 
charactersitics. The purpose of this has been made 
clear to me.  
 
I will be required to record any dietary information and 
wear an accelerometer to measure physical activity for 
seven days prior to the first experimental visit and two 
days prior to each subsequent experimental visit. 
 
I will have my arterial blood pressure measured during 
each visit by placing a cuff around my bicep which will 









Name of Participant  Date  Signature 
     
     
Name of Researcher  Date  Signature 









HEALTH SCREEN FOR CHILD VOLUNTEERS (PARENTAL FORM) 
 
Name:   ………………………………….. 
 
It is important that volunteers participating in research studies are currently in good 
health amd have had no significant medical problems in the past. This is: 
 
i) To ensure their own continuing well-being 
ii) To avoid the possibility of individual health issues confounding study 
outcomes 
 
Your answers to the questions in this questionnaire, on behalf of your child, are strictly 
confidential. 
 
Please complete this brief questionnaire to confirm your child’s fitness to 
participate: 
 
1. At present, does your child have any health problem for which they are: 
(a) On medication, prescribed or otherwise …………. YES   □  NO 
□ 
(b) Attending a general practitioner ………………….         YES   □  NO
 □ 




2. In the past two years, has your child had any illness that required them to: 
(a) Consult your family GP…………………………..         YES   □  NO
 □ 
(b) Attend a hospital outpatient department …………         YES   □  NO
 □ 






3. Has your child ever had any of the following: 
(a) Convulsions/epilepsy …………………………….         YES   □  NO
 □ 
(b) Asthma …………………………………………...         YES   □  NO
 □ 
(c) Eczema …………………………………………...        YES   □  NO
 □ 
(d) Diabetes …………………………………………..        YES   □  NO
 □ 
(e) A blood disorder ………………………………….        YES   □  NO
 □ 
(f) Head injury ……………………………………….        YES   □  NO
 □ 
(g) Digestive problems ……………………………….        YES   □  NO
 □ 
(h) Heart problems ……………………………………       YES   □  NO
 □ 
(i) Lung problems ……………………………………        YES   □  NO
 □ 
(j) Problems with bones or joints …………………….       YES   □  NO
 □ 
(k) Disturbance of balance/coordination ……………..        YES   □  NO
 □ 
(l) Numbness in hands or feet ……………………….        YES   □  NO
 □ 
(m) Disturbance of vision ……………………………..         YES   □  NO
 □ 
(n) Ear/hearing problems ……………………………..         YES   □  NO
 □ 




(p) Kidney or liver problems …………………………          YES   □  NO
 □ 
(q) Allergy to nuts ……………………………………          YES   □  NO
 □ 




4. Do you know of any other reason why your child should not engage in physical 
activity? 
 YES    □   NO
  □ 
 
 
If YES to any question, please describe briefly (for example, to confirm the problem 
was/is short-lived, insignificant or well controlled). 
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The influence of participant characteristics on blood vessel function following consumption of 
a sugary drink in adolescent boys and girls 
 
Contact details Form  
 
Please provide as up-to-date information as possible. This information will be used in case we 
need to contact you due to a change in plans, or in the unlikely event of an emergency. 
 












(please provide a direct contact 
number in case of emergency) 
Home: 
 
Mobile: 
 
Work: 
Email address 
 
 
